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Abstract 
Background: 
Ministry of health provide iron supplementation for the pregnant women to prevent iron 
deficiency anaemia (IDA) and only haemoglobin level test is done for assessing anaemia in 
the pregnant women. 
 
This study aims to determine the nutritional, sociodemographic, gynecological and obstetrical 
factors that may affect iron deficiency anemia in pregnant women who attend the primary 
health care clinics of Ministry of health (MOH) – West Bank. 
 
Methods: 
 
Matched maternal age and gestational age case-control study was conducted from June, 2017 
to May, 2018 among pregnant women who initiated antenatal care follow up in the antenatal 
health care clinics during their first and third trimester, a sample of 342 was selected   from 
three major clinics and three minor clinics in cluster systemic sampling method from the 
north, centre and south area of West-Bank / Palestine. 
 
A self-administered questionnaires was filled after getting an informed consent from the 
women, the antenatal care file of each pregnant woman was reviewed to obtain information 
about blood haemoglobin of the mother and to review the health state. Also, 3 days food 
record instrument was used to collect dietary data, women were requested to record estimated 
foods in cups or spoons and beverages as they were consumed throughout the reported three 
days .Food records were analysed using super tracker, 2011, USAID to obtain micro and 
macro –nutrients. 
 
After data collection, statistical analysis was performed using SPSS software (version 23, 
SPSS), logistic regression analysis was implemented. Distribution, frequencies, and cross-
tabulation were, 95% confidence interval and p-value <0.05 for statistical significance was 
considered. T-test, one way ANOVA test, Chi-square test were used.  
  
IV 
 
Results: 
The results indicated that, lower educational level, Smoking, economic status had significant 
positive association with IDA (OR=1.5, 8.833, 1.9 respectively). 
Parity of deliveries, repeated abortion, period between current pregnancy and previous (child 
spacing), density of menstrual cycle were all significantly positively associated with IDA 
(OR= 2.242, 12.326, 5.723, 4.134, 9 respectively). 
There were significant association between protein, iron, and vitamin C intakes and IDA (OR= 
2.242, 12.326, 5.723, 4.134, 9 respectively).  
Participants‟ fat and carbohydrates intake were not enough to protect against anemia. (OR: 
1.055, 1.017 respectively) (p = 0.062). 
 
Number of meals per day is negatively associated with IDA (OR=0.327, 95% CI=0.162-
0.663)( p< 0.002) .   Increase in appetite to food during pregnancy is negatively associated 
with IDA (OR=0.348, 95%CI=0.190-0.638), (p, 0.001).  
Conclusion: 
The gynecological factors that cause increase in blood loss are positively associated with IDA 
.i.e. OCP and loop use, multiparty, recurrent abortion. 
The lower educational level, Smoking, economic status have significant positive association 
with IDA. 
The nutritional factors has a major role in IDA and further studies must be done in this field 
 
 
 
 
 
 
 
 
 
Vالعوامل التغذویة المؤدیة الى فقر دم ناتج عن الحدید في الحوامل في الضفة الغربیة 
اعداد: نیفین وجیه عبد  الفتاح شلالفة 
اشراف: د. امیرة عمر  
 الولخص
من فقر دم الحديد أثناء الحمل  ةبتزويد النساء الحوامل بأقراص الحديد كوقاي ةالفمسطيني الصحةتقوم وزاره 
 لمنساء الحوامل . فى الدم الييموغموبين مستوى لات فقر الدم من خلال قياسيم حاويتم تقي
الى فقر دم الحديد لدى النساء الحوامل اضافو الى  المؤدية ةتحديد العوامل التغذويالى  الدراسةتيدف ىذه 
 . الإنجابية الصحةوعوامل  الاجتماعيةتأثير العوامل 
الحمل  رعايةيتابعن  اللاتياستيدفت النساء الحوامل  والتيشاىد وال الحالة دراسةعباره عن  الدراسةىذه 
منذ  الغربية الضفةفي ثلاث عيادات رئيسيو وثلاث نقاط صحيو في  الأولية الصحية الرعايةفي عيادات 
امرأه وقد تم اختيار العينات  742 العينة, ولقد شممت   2017الى شير يونيو  2017شير مايو لعام 
 وعمر الحمل . للام الحالات والشواىد مع مطابقو العمرمناصفو ما بين 
، بالمشاركة الموافقةبعد توقيع كل المشاركات عمى نموذج  اتستبيانمت تعبئو المشتركات في الدراسو للات
اليامو عمى مستوى  ةوضبطت القيم  )27 النسخة   )SSPSثم تم تحميل البيانات باستخدام برنامج 
 : ةالتالي ةمج الحسابيالبرا. وتم تطبيق  01.1
 ) .tset erauqs-ihC , tset AVONA yaw enO ,tset-T .(
أيام من بينين يوم  ثلاثة ةلمد ء المتناول بكل مواصفاتو وكمياتو ااضافو الى ذلك تم تعبئو سجل لمغذ
 1102,REKCART REPUSعطمو , ثم تم تحميل محتويات الغذاء باستخدام برنامج 
 IV
 
 والحالة والتدخين  مستوى التعميم رتباط قوي ايجابي بين فقر الدم و أن ىنالك ا الدراسةأظيرت نتائج 
 بالترتيب  (=RO )9.1 ,8.8 ,5.1 الاقتصادية
كان ليا  ةالشيري ةما بين الحمولات واضطرابات الدور وتباعد المسافات  ةالمتكرر عدد المواليد والاجياضات 
 لا يعانين من فقر الدم  اللاتيمن فقر الدم مقارنو بالنساء  عند النساء المواتي يعانين الارتباط الايجابي
 .بالترتيب )5.9 ,431.4 , 327.5 , 623.21 , 242.2 =RO(
يعانين من فقر الدم  اللاتيبين الحوامل  كان ليا تأثير كبير وفرق واضح ما ةكما وأن العوامل التغذوي
يلاك اليومي من الحديد وفيتامين سي والبروتين أن مستويات الاست الدراسةلا يعانين اذ أظيرت  واللاتي
 .لا يعانين من فقر الدم  الاتيلدى الحوامل  عاليةكانت 
 بالترتيب )9,431.4,327.5 , 623.21 , 242.2 =RO(, 
 أظيرتا ارتباطا سمبيا مع فقر دم الحديد لمنساء الحوامل  خلال الحمل الشييةعدد وجبات الطعام وزياده 
  ,)200.0 <P(,)366.0-261.0=IC %59 ,723.0=RO(
 .)100.0 ,p( ,)836.0-091.0=IC%59 ,843.0=RO( 
لقد أثبتت الدراسو أن العوامل النسائيو والانجابيو كاستخدام أقراص منع الحمل او المولب لتنظيم الحمل و 
حوامل , كما وأن زياده عدد المواليد وتكرار الاجياضات مرتبطو  ارتباطا ايجابيا بفقر دم الحديد لمنساء ال
العوامل الاقتصاديو والاجتماعيو تحمل نفس الارتباط مع فقر الدم لمحوامل , ومن ىذه العوامل التدخين 
 والحالو الاقتصاديو ومستوى التعميم .
الى فقر الدم ونحن بحاجو ماسو الى اجراء  المؤديةأن الغذاء ىو أحد أىم العوامل أثبتت الدراسو كما و 
 ذا المجال .بحوث أكثر في ى
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1. CHAPTER ONE: BACKGROUND 
1.1 Introduction 
 
Anemia is a state of hemoglobin concentration much less than the regular level for the precise 
age, gender, and physiological circumstance (WHO, 2016). Iron deficiency is a the 
circumstance that on account of little iron inside the frame that range from iron depletion to 
deficient in erythropoiesis and to iron deficient anemia (IDA), and it is taken into 
consideration that IDA has an effect on billions of human beings everywhere, pregnant ladies 
are one of the essential groups which can be dramatically laid low with iron deficiency anemia 
(Abdelrahman et al, 2012). 
Globally, IDA is discovered in extra than 20% of maternal death (WHO, 2016). Moreover, the 
anemia prevalence is higher within the first and third trimesters than in the 2d   (ACOG, 2008, 
WHO, 2016). 
Pregnancy  is considered as  one  of  the  most  crucial  and  unique periods  in  a  woman‟s  
life , the care given  by  the  health care provider to a pregnant woman during her 280 days of 
the pregnancy period is known as antenatal care and iron deficiency is highest among infants, 
children and pregnant women (Ahmad et al  ,2011). 
 IDA  in  pregnancy is considered  the commonest nutritional deficiency disorder all over the 
world and it is identified and confirmed during antenatal  visits by  means of simple  
haemoglobin level (HB) ,(Ahmad et al ,2011).  It is  estimated  that  more  than  50%  of 
pregnant ladies are diagnosed with anaemia and majority (90%) are due to  iron  deficiency 
(ACOG ,2008 ). 
In pregnancy, hemoglobin level (HB)  less than 11 gm/dl is identified as anemia in both the 
first and the third trimesters, but in the second trimester anemia is defined as Hb level less than 
10.5 gm/dl (WHO ,2016). 
Many factors may lead to iron deficiency anemia in general and spicily during pregnancy, iron 
deficiency considered as the most common contributing factor of the development of anemia 
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in pregnancy hence the pregnant woman cannot achieve the increased requirement of iron by 
diet alone (Beger et al, 2011). 
Other nutritional factors include, nutritional deficiencies (i.e. vitamin C), nutrient-nutrient 
interaction (i.e. iron and calcium), drug nutrient interaction (i.e. H2 receptor blockers), as 
treatment for the ulcers and many other gastrointestinal problems and iron). Food habit and 
meal pattern (WHO, 2015). 
The socioeconomic conditions such as the age, parity, income, housing, family size and 
education, play an important and crucial role in developing of iron deficiency anemia 
(Abdulrahman et al, 2012). 
Blood loss,  any defect in metabolism, chronic illnesses and hemolysis are also important 
factors that affect and effected by  IDA and determine the level of IDA complications (ACOG, 
2008). 
Iron deficiency anemia may additionally purpose many complications that may affect the 
mother and her unborn baby. those encompass maternal and fetal death, terrible performance 
in mental and psychomotor baby test, respiratory problems as pneumonia, and pulmonary 
infarction , also some infantile complication as  intra uterine growth retardation, low birth 
weight babies, abortion, stillbirth and prematurity (Rahman et. al, 2016). 
1.2 Problem statement 
 
 IDA is a global important health phenomenon worldwide where 41.8% of pregnant women 
have IDA in Asia (Rahman et al, 2016). IDA leads to 115000 maternal deaths and   a lot of 
prenatal death, about 59100 death per year (WHO, 2016). 
Many factors contributes to IDA, such as, increase of the physiological demand , iron and 
vitamin C deficiency , chronic disease and multiple comorbidity  ,intestinal parasitic 
infections, , blood loss, abnormal hemoglobin synthesis, ( Stevens et al, 2013; Alene et al, 
2014). 
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Ministry of Health (MOH) program for antenatal care aims to prevent and treat IDA through 
providing iron supplement for pregnant women who attend and receive their care in the MOH 
primary healthcare clinics. 
In spite of the fact that the Palestinian ministry of health has protocols for control of iron 
deficiency anemia in pregnant women booked and receiving the pre natal care at the MOH 
clinics, the prevalence of anemic pregnant mothers turned into 29.5%. Which is high in 
general (MOH 2015) 
Palestinian programs that are applied to prevent and control nutrition related disease (i.e. iron 
deficiency anemia) are insufficient and ineffective , it is  focusing  on the therapeutic care 
rather than the  prevention  care , there is also a lack of nutritional surveillance, lack of 
nutritional intervention or assessment of effective nutritional intervention  programs 
(Abdulrahman et al, 2011). 
This study is aimed to analyze the underlying nutritional and the sociodemographic factors 
that affect this health problem (IDA) among pregnant women. 
1.3 Justification of the study 
 
 The Palestinian Ministry of Health program in the West Bank provides primary health care 
services for pregnant women in their primary healthcare clinics (PHC). The MCH (maternal 
and child health) services aim to prevent anemia by providing the iron supplement tablets and 
the laboratory tests for each pregnant woman attending the clinics to assess hemoglobin level 
and prevent anemia. 
Prevalence of IDA among Palestinian pregnant women is 29.5 % which is two times higher 
than that in Europe (MOH, 2015). IDA is a major health problem of multifactorial nature such 
as socioeconomic state (age, parity, income, housing and education), compliance to 
supplementation, dealing with medications, the nutritional status and the dietary habits.  
Malnutrition is considered as the main leading cause of anemia in developing world (Aspura, 
2011). Iron deficiency is the most common malnutrition factor (Milman et al , 2011,WHO 
2016). 
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Pattern of meal, nutrients iron interaction and drug-iron interaction play an important role in 
iron deficiency  , enhancers of  the absorption of iron include vitamin C, which is desired to be 
eaten seriously with iron containing foods ( Gibson et al , 2005 , WHO,2011 ). 
Many research achieved that verify the awareness about anemia amongst being pregnant  and 
plenty of published research executed to assess  the etiology of  IDA  in pregnancy , however 
there is missing of studies this is focusing at the dietary elements that may have an effect on 
IDA  in our community although ,  over the past 30 years ago the socioeconomic conditions  
have been changed in our country and other Arab and international region which resulted for 
this reason in adjustments within the dietary conduct and forms of food that is consumed 
which may also have an effect on the health and the iron level (Abdulrahman et al, 2011).  
Based on the above, it‟s miles apparent that IDA is a preventable situation and well worth 
studying to lower the prevalence and to enhance the overall health of the pregnant women and 
their babies, there‟s loss of studies that cope with IDA underlying nutritional and 
sociodemographic elements within the West Bank.  
This study may enlighten public health policy makers and the Palestinian Ministry of Health to 
prevent IDA in pregnant women. 
 
1.4. Aim of the study 
 
To determine the nutritional and sociodemographic factors that may affect iron deficiency 
anemia in pregnant women who attend the primary health care clinics of MOH – West Bank. 
 
1.4.1. Objectives: 
 
1- To determine the sociodemographic factors associated with IDA in pregnant women 
attending the (MOH) clinics in the West Bank. 
2- To assess the nutritional factors that may play a role in IDA during pregnancy. 
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3- To assess the role of the obstetrical and gynecological factors for the pregnant women in 
developing IDA. 
 
1.5. Feasibility of the study  
 
The MOH always facillate the access to the clinics and getting the information also the 
health staff as the researcher is a staff member of the health team of the MOH . 
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Chapter tow: literature review 
 
2.1. Iron deficiency anemia (IDA) 
 
Anemia is a common public health problem, (Milman, 2011) that is causing an unfavorable 
status in pregnancy and even in all others (Milman , 2011). 
Pregnant women and young children are at higher risk of mortality and morbidity due to 
anemia because of its consequences and  the complications that may occur , IDA  leads to 
hemorrhage, maternal infection, thrombosis , premature labor, intra uterine growth restriction 
or death , low birth weight and maternal and perinatal mortality,( WHO,2016). 
The primary causes of anemia during pregnancy are inadequate intake of dietary iron ,greater 
fetal demand, and increased blood volume during pregnancy, (WHO, 2016), Although iron 
absorption is high during pregnancy but  the amount of dietary iron absorbed and mobilization 
of the iron stores are not enough to meet the demand for both the mother and her fetus  (WHO 
,2016). 
Many factors as low education levels, teenage pregnancy, multiple births, poor nutritional 
status, wrong food habits, parasitic infections, iron supplementation, and abortion are related 
to IDA (WHO ,2016). 
 
2.1.1. Definition of IDA in pregnancy: 
 
According to the World Health Organization (WHO), IDA in pregnancy refers to a level of Hb  
much less than 11 g/dl in the first and third trimester and 10.5 g/dl  within the 2d trimester 
(WHO, 2017).  it can be also identified as circumstance  in which the number of red blood 
cells  and their oxygen-carrying capability is insufficient to meet all of the physiologic 
demands inside the body, which range from one to another depending on  age, sex, altitude, 
smoking, and the pregnancy health condition (WHO, 2016) . 
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2.1.2. Stages of iron deficiency: 
 
First stage: Iron depletion 
In this stage ,the  bone marrow iron stores is reduced , Hb and serum iron is mostly normal, 
however serum ferritin degree falls to < 20 ng/ml , iron absorption and iron binding capacity is  
increased  as well as the transferrin level ,(Mayo ,2016). 
 
Second stage: Iron deficiency ( ID) 
Despite the fact that the transferrin level is elevated but erythropoiesis is impaired when serum 
iron falls to < 50 μg/dl (< 9 μmol/l) and transferrin saturation to < 16%  , the serum iron level 
decreases and the transferrin saturation decreases also ,The serum transferrin receptor level 
rises (> 8.5 mg/l) and considering the total iron-binding capability its level is  is( 250 to 450) 
μg/dl (45to 81 μmol/l) ,in ( ID ), when iron-binding capacity increase the transferrin saturation 
decrease ,(Khalafalla et al ,2012).   
 
Final stage (IDA): 
The iron stores are depleted to a degree where they could not produce the hemoglobin needed 
to make enough red blood cells, this level is characterized by decrease in the Hb  levels, blood 
tests at this level will show serious and significant low hemoglobin level and hematocrit . One 
of the main characteristic of this stage is the development of microcytosis and then 
hypochromia ,(Khalafalla et al ,2012 , Mayo ,2016). 
 
2.1.3. Prevalence: 
The worldwide prevalence of  IDA in pregnancy is range from 35 to 60% .It is less than 20%  
in the industrialized international locations ,Inside the USA, the lowest  prevalence  (5.7%)  
,and the highest is  75% in Gambia,  the IDA prevalence is(  65–75) % in India (WHO ,2015). 
Prevalence of IDA among Palestinian pregnant women is two times higher than that in 
Europe, which is 29.5% in West bank. In Jordan it is 27.4% (WHO, 2016) 
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 According to the  (WHO), the prevalence of IDA is  9% in the developed countries and 41% 
in the developing countries  (WHO ,2015) , Globally and  despite all the efforts to control 
IDA, it is main cause for more than 11500 maternal death and 591,000 prenatal death per year 
(Balarajan et al, 2013). 
 
2.1.4. Etiology of  IDA : 
 
Iron deficiency is the common nutritional deficiency which present in 75% of all anemia types 
that affect the pregnant women. The diet plan in pregnancy play an essential rule in prevention 
or development of IDA (  Chandra et al, 2015)  . 
Many physiological modifications occur for the duration of the pregnancy, there may be a 
physiological hemodilution, with a peak all through 20–24 weeks of gestation (milman et al , 
2012),and the physiological drop in Hb that arise mainly in the  mid-trimester. this drop is 
because of the high increase in plasma quantity, as compared with RBC mass, which barely 
increases all through being pregnant , this physiological changing produces relative hem 
dilution, blood viscosity, helping in the proper circulation of the blood into the placenta 
(Chandra et al ,2015). 
 IDA is a result of many factors such as poor nutrition, iron deficiency, micronutrients 
deficiency as vitamin C low levels, gastrointestinal  illnesses together with malaria, hookworm 
and schistosomiasis , HIV infection and genetically inherited hemoglobinopathies, along with 
thalassemia is a very important cases that must always rule out, there also may be also a likely 
association between helicobacter species infection and IDA (ACOG ,2008). 
 
In developing countries, iron-deficiency anemia is generally the end result from inadequate 
dietary intake and poor nutrition, intestinal worm infections that may cause bleeding, or both 
,but  in high-income nations, some eating habit as being vegetarian  with no consumption of 
beef  and some chronic blood loss pathological conditions associated with malabsorbtion are 
the main causes( Salamet al ,2009,Sharma et al,2007). 
 
Many of the pregnant women begin pregnant with poor iron stores,(Milman et al, 2012) , so 
the quantity of iron absorbed from eating regimen, together with that mobilized from the 
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stores isn't always sufficient to satisfy the maternal needs in pregnancy ,moreover, the 
increased iron demand during pregnancy is relatively  the common  cause of IDA (Milman et 
al, 2012). 
Poverty is an important cause of anemia in the residents of the  iron deficiency developing 
nations, mainly kids and pregnant women ,also the cereal-based diet  plan  that decreases iron 
bioavailability due to the fact phytates in grains sequester iron in a poorly absorbable complex 
(Zimmermann et al 2011) . Different not unusual reasons include the blood loss due to heavy 
menstrual cycle or gastrointestinal bleeding (ACOG, 2008). 
 
The availability of iron is considering as the main rate proscribing factor for RBC 
manufacturing via bone marrow and so, when  iron is poor the iron stores in bone marrow 
decrease and serum ferritin degree falls associated with decrease inside the erythropoiesis, the 
serum ferritin <30 μg/l is a marker of depleted iron stores , (Mayo,2016). 
 
2.1.5. Symptoms of iron deficiency anemia: 
 
IDA is classified as , mild , moderate and sever , if  Hb  10–10.9 mg/dl then IDA is mild, 
moderate  if  Hb level of 7–7.9 mg/dl  and severe if  Hb level is <7 mg/dl (WHO ,2016) 
The symptoms and complains are unnoticeable at the beginning of the first stage and then it is 
developed to be sever. Fatigue  ,weakness ,pallor of the  skin ,dyspnea , being dizzy and un 
steadiness , eating items that are not food .i.e. soup ,soil, ice ,which is called  (pica)   ,coldness 
of  hands and feet , tongue swelling or even  soreness ,  tachycardia and headaches ( Chang et 
,2013 ). 
At some point of pregnancy, many dangers and risks affect the IDA women that may threat 
the health for women and their babies i.e. , extended fatigue, short-term memory loss, reduced 
interest and decreased overall performance at work, also the low Hb and  blood oxygen 
saturation increase the pressure on the cardiac system which is a very serious issue in 
pregnancy , lower resistance to infections and blood loss at some point of exertions 
(Zimmerman et al ,2007) . Cognitive abnormalities and some behavioral abnormal issue may 
affect the the iron-deficient neonates up to 10 years after iron repletion (Siddiqui et al ,2008). 
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2.1.6. Diagnosis of (IDA): 
 
First of all , the clinical picture for the pregnant woman is very important , mainly conjunctival 
pallor ,the oral mucosa, the nail beds  also with palmar creases are may be  pale too which is 
correlated negatively with Hb level , the severity of anemia can easily evaluated be accurate 
physical examination  if laboratory tests are not available (ASH, 2016). 
2.1.6.1. Full blood count and MCV value: 
 
Allowing the diagnosis of microcytic anaemia and is considered a good screening tool ,In  the 
cases  of iron deficiency anemia, a complete cell blood count shows reduced Hb concentration,  
reduced MCV  ,reduced  the mean cell Hb concentration and mild thrombocytosis (Mayo, 
2016). 
2.1.6.2. The serum ferritin level: 
 
It is a marker of depleted iron stores with a cut off value of <30 μg/l (ASH , 2016). The iron 
availability is the rate limiting factor for RBC production by bone marrow, as the  iron stores 
in bone marrow decreases the serum ferritin level falls and erythropoiesis starts to be impaired 
epically when serum iron is <50 μg/dl (Mayo,2016). 
Serum ferritin is a parameter of acute-phase reaction,  its concentration increases in many  
cases  i.e.  infections, any  systemic inflammations, cancers,  chronic renal failure and so low 
levels of serum ferritin is diagnostic of IDA  but normal values cannot exclude the iron 
shortage, and in that situation diminished transferrin saturation  is diagnostic (Kalafallah et 
al,2012). 
According to the ferritin level, iron deficiency can be classified as severe ID when the ferritin 
level is <30µg/L or mild-moderate ID if ferritin <100µg/L and >30µg/L ( Khalafallah et al 
2012). 
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2.1.6.3. Peripheral blood smears: 
 
Underneath a microscope investigation for to determination of the size, shape, quantity, and 
look in addition to evaluate other cells inside the blood  to find microcytic hypochromic cells 
with anisocytosis and poikilocytosis, , ( ASH, 2016). 
2.1.6.4. Bone marrow iron stores: 
 
It's far the definitive marker of iron deficiency, however it is an invasive manner to apply for 
most patients, ( Mayo,2016). 
2.1.6.5. Reticulocyte hemoglobin content: 
 
It is a marker of cellular Hb content, the sensitivity of this test is 93.3%, and it must be taken 
in consideration with iron and transferrin level (Mayo, 2016) 
 
 Iron level: 
Anemia may be related to iron deficiency or not  and this test is used to differentiate usually 
accompanied by other tests that measure the body's iron storage capacity, such as transferrin 
level and ferritin level  ( Khalafallah et al 2012). 
 
 Transferrin level: 
- Evaluates a protein that transports iron in the body and Ferritin level that  
evaluates  the total iron available in the body,. 
- Soluble transferring receptor concentration: 
 
It is directly proportional with cellular receptor density, revealing total iron demand ,  
this parameter unaffected  by the  inflammatory  states and chronic diseases (Mayo. 
2016) 
14 
 
 
 
 Amphipathic b-sheet hairpin peptide (HAMP) 
It is expressed mainly in the liver, as an extended precursor  of hepcidin ,it could be a 
beneficial marker to evaluate iron availability at some stage in being pregnant, however there 
are few available studies in literature, and maximum of them involve a small range of pregnant 
patients (ASH, 2016). 
 
2.2. Iron and pregnancy 
 
2.2.1. Iron requirement: 
Extra requirements of iron are needed from puberty to menopause due to the physiological 
modifications and because of excessive blood loss at some point of menstrual cycle. as an end 
result, iron deficiency is maximum commonplace amongst women in the reproductive age in 
both developing and evolved countries (Haniff et al, 2007). 
There is tow dietary form of iron: heme and nonheme , nonheme iron is present in many plants 
and iron-fortified ingredients , whereas meat, seafood, and hen incorporate each heme and 
nonheme iron ,which contributes approximately 10% to 15% of general iron intakes and  is 
formed when iron combines with protoporphyrin (Kaufman , 2016) . 
 
Typically, iron requirement steadily will increase till the third month, in parallel with the 
accumulation in fetal tissues, the predominant causes of iron deficiency include insufficient 
intake of iron-rich ingredients and poor bioavailability, iron demand increases about six to 
seven instances from early pregnancy to the overdue pregnancy (Christensen et al , 2004). 
 
Anemia in pregnancy is a gold slandered indicator that reflect poor health and nutrition, 
drinking tea often with meals is one of the maximum commonplace bad habits among 
pregnant women and everyone others mostly, tea incorporates a substance referred to as 
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(tannin) and research revealed that ingesting tannin with meals can extensively decrease the 
iron absorption by 60% , coffee also decrease the iron absorption by 50% (Kaufman ,2016) . 
 
2.2.2. Iron supplementation during pregnancy: 
 
During pregnancy  , the pregnant needs 27 milligrams a day of iron , which is double the 
amount needed by women who are not pregnant, This iron is recommended to improve  the 
pregnancy and its effect on the mother and the baby , the mother health and birth outcomes 
(Sharma et al , 2003 , ACOG 2008 ). International recommendations in terms of intake levels 
(27 – 30) mg per day for all pregnant women as advised by the Center for Disease Control and 
Prevention and the WHO ,( WHO , 2016 ). 
 
Iron tablets are one of the main supplements for the pregnant women in the ante natal care 
clinics because it is difficult for many women to reach the requirement of iron (Scholl et al, 
2011). The use of iron during pregnancy is a preventive tool to improve maternal 
hematological status in general and to improve the baby weight and health and so the WHO 
has long recommended the prenatal use of iron (WHO, 2015). 
 
Pregnant women need additional amounts of minerals to prevent IDA such as vitamin C, a 
good source of vitamin C at the same meal when eating iron-rich foods  is recommended , for 
example, have a glass of orange juice at breakfast with an iron-fortified diet is available (  
Scholl et al, 2011).Reduction in intake of  vitamin A and vitamin C; the absorption promoter 
of the non-heme iron play significant rule of IDA (De Bonset et al,2005). 
 
 
Milman et al studied the gastrointestinal side effects of iron supplement in pregnancy by 
randomizing blindly 404 healthy women in four groups receiving varying amounts iron as 
supplement  (20, 40, 60 or 80 mg of iron/day as ferrous fumarate. The results showed little 
difference in gastrointestinal effects between the different levels of supplemental intake and 
compliance to supplement intake was also reported to be similar. But constipation and black 
feces are more frequent in those taking 80 mg/day (Milman,et al, 2006). 
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2.2.3. MOH program for iron supplementation and pregnancy care in 
Palestine: 
MOH in Palestine adopted the WHO recommendations and program  for the iron 
supplementation of the pregnant women  which consider iron as a very important supplement 
tablet for all the pregnant women in the anti natal care clinics it is given for the pregnant 
women for free. 
  
Iron and folic acid supplementation program should ideally form part of an integrated program 
of antenatal care that promotes adequate gestational weight gain and should be given from the 
13 week of pregnancy till 6 weeks post-delivery .(WHO 2016). 
 
Oral supplement of 30 mg iron is available for free among pregnancy as capsules or tablets 
(soluble, tablets, dissolvable and modified-release tablets), (WHO 2012). 
 
2.3. The nutritional factors affecting (IDA) 
 
Dietary sources of iron come in two forms: heme and nonheme iron.  
• Heme iron is found in animal products, such as red meats, fish, and poultry.  
• Nonheme iron is found in plant foods such as lentils and beans, and is found in iron-
enriched and iron-fortified foods. 
 Nonheme iron is less efficiently absorbed into the body than heme iron and need enhancers as 
vitamin C. ( Haufman , 2016)  
2.3.1. Nutrient-Iron Interaction: 
The interaction with any other nutrient within the complement or in meals that affect the 
absorption or utilization of iron .i.e. adding 50 milligrams of vitamin c to an iron- meal  triple 
the absorption of iron ( Haufman , 2016) 
 
17 
 
Advanced deficiency of vitamin A is considered serious state that is, it affect formation of the 
RBC  ( ASH ,2016) 
Bioavailability of food iron is strongly stimulated by means of enhancers and inhibitors in the 
diet consumed, and  iron  absorption can range from 1% to forty%, depend on the mix of 
enhancers and inhibitors that is found in the diet.(WHO, 2001) 
 
Enhancers of iron absorption include: (WHO,  2001) 
1- The haem iron, which is found in meat, and seafood  
2- Vitamin C  which is very important and available , it can be found in fruits, potatoes and 
some vegetables i.e. green leaves 
Inhibitors of iron absorption include: (WHO, 2001) 
1- Phytates: one of the most important absorption inhibitors that is found in cereal grains, 
legumes, seeds and nuts. 
2-   Inositol material;  
3- Tannins: it is the strongest inhibitors proof against the impact of enhancers .i.e. tea,  cocoa, 
herbals as oregano and coffee. 
4-   Milk and milk products that contains calcium. 
 
2.3.2. Drug-Iron Interaction: 
Food will have an effect on the manner a medication works by way of increasing or decreasing 
the quantity of medicine and absorption, food actually affect the rate at which the body 
process or remove the medications. 
 Iron affect the absorption of many medicinal drugs. for that reason, it's miles pleasant to take 
iron dietary supplements as a minimum 2 hours earlier than or 2 hours after taking some 
medications as tetracyclines , doxycycline , minocycline and  quinolones that include 
ciprofloxacin , norfloxacin and levofloxacin  (Haufman , 2016) 
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2.3.3. Meal pattern: 
It is an overarching construct that is often used to describe individuals‟ eating patterns at the 
level of a „meal‟, such as a main meal (for example, breakfast, lunch or dinner) or a smaller-
sized meal (for example, supper or snack), (Meiselman,2009). 
 
The neutral terms „eating occasion‟ (EO) or „eating event‟ are also used to describe any 
occasion where food or drink is ingested, and therefore incorporates all meal types. Meals 
have been described according to three constructs:  
 
 (1)  patterning (for example, frequency, spacing, regularity, skipping, timing) 
(2) format (for example, types of food combinations, sequencing of foods, nutrient 
profile/content). 
 (3) context (for example, eating with others or with the family, eating in or out of home) . 
(Meiselman,2009). 
 
Inadequate intake of some kinds of heme iron rich food as chicken is significantly associated 
with anemia and the high consumption  is associated with lower prevalence of anemia (Baig et 
al ,2008) , this finding was written in the report of WHO, which stated that in developing 
countries inadequate intake of dietary iron is the main causes of anemia during pregnancy (De 
Benoist et al, 2008). 
 
There are many variables for the meal pattern such as: 
1- Frequency of eating occasion (EO) : the mean number of meals and snacks per a day 
which is usually measured by 24 hr Dietary recall , weekly food diary ,  and meal 
patterns questionnaire (Bellisle et al ,2003) . 
 
2- Regularity of meals which is defined as the consistency of EO frequency and spacing , 
,and one of its methods of assessment is food records (3days), ( Haufman , 2016). 
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3- Meal skipping usually omits breakfast, lunch or dinner (Smith et al, 2010) , Single 
questionnaire items and meal patterns questionnaire are used to assess it ( Smith et al, 
2010). 
 
2.3.4. Energy during pregnancy: 
 
Extra requirement of 69 kcal/d for the first trimester, 266 kcal/day for the second one and 496 
kcal/day within the last trimester of being pregnant is needed , in general, additional 76,530 
kcal is needed (ACOG ,2008). 
 
2.3.4.1. Macronutrients for pregnant woman 
 
1- Protein 
Protein requires more attention during pregnancy among all the macronutrients  to support 
protein synthesis, in order to maintain maternal tissues and fetal healthy growth, mainly during 
the third trimester  (Kaufman ,2016) 
During pregnancy, it should be increased by 1 g/day in the first trimester, 8 g/day in the 
second trimester, and 26 g/day in the third trimester (Kaufman ,2016). 
 
2- Fat 
During pregnancy, the quality of fats is more important than their total amount, especially for 
fetal development and infant growth. But  during pregnancy and lactation it is thus not 
necessary to change the overall fat intake (Koletzko et al 2007). 
 
3- DHA 
DHA is the major polyunsaturated fatty acid, it is essential for brain and retinal development 
of the fetus during pregnancy, Inadequate intakes are associated with low consumption of fish 
rich in omega-3 (Koletzko  ,2011). 
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2.3.4.2. Micronutrient during pregnancy 
 
1- Iron 
Meat, fish, legumes and green leafy vegetables are the main dietary sources of iron. The 
absorption of iron is closely linked to the overall  diet and the individual nutritional status. For 
example, phytates and polyphenols are able to inhibit the absorption of non-heme iron, which 
is favored by ascorbic acid or by the consumption of meat and fish, generally, the human body 
is able to absorb 2%–13% of non-heme versus about 25% of heme iron (Koletzko  ,2011). 
 
International recommendations in terms of intake levels range from the 27 mg per day for all 
pregnant women as advised by the Center for Disease Control and Prevention and the WHO to 
the 30–60 mg as advised by the Italian RDA . 
 
2- Folic acid 
There is great need to supplement maternal folic during pregnancy, through food fortification 
or via the use of supplements in the preconception period (Berti et al, 2016). 
The RDA during pregnancy increases by 50% for pregnant as compared with non-pregnant 
women of childbearing age (600 µg/day vs. 400 µg/day). Folic acid should be given two 
months before conceiving and till reaching 800 µg/day (US Preventive Services Task Force 
2009). The use of folic acid-based supplements is considered as safe (Berti 2016). 
. 
3- Vitamin D 
There is no homogeneous consensus on its recommended intakes, but generally it is 
importance as prophylaxis from deficiency, during pregnancy and breastfeeding (Edward et ai, 
2010). 
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2.4. Socio demographic factors that affect IDA in pregnancy: 
 
Sociodemographic factors means the important background information about the population , 
such as age, sex, race, educational status, income, and geographic location. 
It is recommended that the socio-economic status of women should be enhanced in line with 
the Millennium Development Goals to prevent anemia and to enhance pregnancy outcomes 
(WHO , 2016 ) , and  during the last 30 years the socioeconomic state of the population has 
been changed in the West Bank and other Arab countries which resulted in changes in the 
nutritional habits and types of food consumed (Abdulrahman et al, 2011). 
 
Socio economic status is found to be a major explanation for the women having IDA  and 
most ladies from low income category were more iron deficient (Sharma et al ,2007) . It is 
proven that poverty is main cause of anemia in the multitude of people living with iron 
deficiency in developing countries, especially children and pregnant women (Sharma et al 
,2007) 
Pregnant women with low educational level is significantly related to the prevalence of IDA 
and sickness (Kefiyalew et al , 2014 ) . Generally, health education is an essential factor to 
reduce the prevalence of anaemia ( Microwsky et al ,1998), so health education and preventive 
measure during pregnancy are crucial factor for both mother and their offspring‟s health 
because each pregnant woman is at risk during pregnancy even low risk pregnancy (Alan et al 
, 2014 , Ahmed et al ,2011 . 
Anemia is usually occur in  teenager mothers due to their unplanned pregnancies and the 
suboptimal nutrition status (Kefiyalew et al , 2014 ) , There is nutritional deficiencies at 
beginning and throughout the primary prenatal period for this age group (Kefiyalew et al , 
2014 ) 
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Smoking 
The recommendation to abstain from smoking in pregnancy is mandatory, because of the 
increased risk of infant low birth weight, respiratory diseases, development of asthma and 
allergy and preterm delivery (WHO, 2016). 
Smoking during pregnancy may also affect breastfeeding: cigarette smoke is resulting in a 
reduced supply of this in related to the infant (WHO, 2015, Subramony et al, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
 
2.5. Conceptual farm work 
 
This study is aimed to describe the nutritional and socio-demographic factors that is related to 
IDA in pregnant women in a primary health care clinics in West-Bank/ Palestine. The study is 
intended to provide beneficial records that would help in figuring out possibly regions for 
precise intervention for the improvement of reproductive health and IDA preventing measures. 
 
 
 
Fig. (2.1): Conceptual farm work of the study 
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2.6. Study variable and operational definitions 
 
2.6.1.   The dependent variable: 
Iron deficiency anemia (IDA):  the hemoglobin concentration of less than 11 g/dl in the first 
and third trimester and 10.5 g/dl in the second trimester. 
2.6.2. The independent variables: 
Occupation: It is what the pregnant women doing, that is, the activities that bring an income 
for her families, It is classified as worker and nor workers. 
Educational level:  Depending on the years of studying, primary school studying (1-10) years  
, secondary (11-12) years, and college or university any more than 12 years . 
Family income: The average of money earned by the family members, lower than 3000 
shekel, or more than 3000 shekel  
Parity: The number of the delivered children by the women. 
Abortion:  Fetus or embryo removal or expulsion from the uterus during the first 20 weeks of 
gestation or less, recurrent abortion if more than three consecutive abortions. 
Contraception method usage: Any method or device used to prevent pregnancy, oral pills. 
Loop (helix), injections, condoms or natural way. 
Child spacing: the period between the current pregnancy and the previous one . 
Micronutrients:  An element or substance (minerals or vitamins) that is essential in minute 
amounts and play major role in iron bioavailability, i.e. vitamin C or calcium. 
Macronutrients:  Chemical element or substance (such as fat, carbohydrate or protein) that is 
essential in relatively large amounts to the growth and health of a living organism.  
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Chapter three: Methodology 
 
3.1 Study design 
 
Matched case-control study was conducted from June, 2017 to May, 2018 among pregnant 
women who initiated antenatal care follow up in the antenatal health care clinics during their 
first and third trimester. Using the WHO definition for diagnosis of anaemia in pregnancy, the 
participant pregnant women were categorized into the case and control group based on the 
haemoglobin level test result on their visit to antenatal care clinics and they were matched 
depending on the mother age and the trimester case group (Hb level <11 g/dl) and control 
group (Hb level between 11 g/dl-15.5 g/dl inclusive), (Mayo .2016, ACOG, 2008, WHO, 
2016). 
 The inclusion criteria: 
 Pregnant women who came for antenatal care follow up during their first or third 
trimester and who are willing to take part in the study after getting informed consent 
during the study period. 
The exclusion criteria: 
 Severely ill pregnant women thus unable to respond to the questionnaire or not willing 
to take part in the study,  
 All the women in second trimester 
 Women with diabetes, hypertension, thalassemia, haemophilia,  
 Any hereditary conditions that prevent iron absorption  
3.2 Sample size determination 
 
Sample size calculations were conducted in the StatCalc module of EpiInfo (EpiInfo™ version 
3.5.1, U.S. Canters for Disease Control and Prevention, Atlanta, GA, USA). The following 
assumptions were considered to determine the sample size :  prevalence of iron deficiency 
anaemia in pregnant women in Palestine is 29.5% , the  study was powered to detect an odds 
ratio of 2.0 with 95% significance and 80% power, case to control ratio 1:1. , and by 
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considering 10% non-response error, the total number of study participants were 342, of these 
171 were cases and 171 were controls. 
 
3.3. Sampling technique 
 
Cluster systematic sampling method: 
Sampling : West Bank was divided  into north ,south and middle operational areas to select the 
study clinics , from each area one major and one minor clinic were randomly selected ( major 
clinics are in cities and minor in villages). 
 
The selected clinics were the following: 
 
1- North area of the West Bank: Nablus district ( Al Makhfya  as a major clinic and 
Queseen as a minor clinic ) 
2- Middle  and central area (Rammalla central clinic and Birzeit as minor clinic) 
3- South area : (AlRamma as central clinic  and Ithna as a minor  clinic) 
 
Numbers of study participants were allotted from each health antenatal care clinic 
proportional to their average client size  by referring the registration books of each 
antenatal care clinic (Table 3.1). Thus, mathematically, average number of pregnant 
women who attended antenatal care in each health facilities multiplied by the total sample 
size (N=342), divided by the total sum average number of pregnant women attended in all 
the antenatal care clinics (1150). 
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Table 3.1:  calculated sample size of pregnant women allocated to each antenatal care 
clinic. 
Health clinics Remaining files Calculated sample Sample cases Control 
Al RAMMA 200 (200/1150 )*132 34 34 34 
ITHNA 160 (160/1150)*132 48 24 24 
RAMALLA 250 (250/1150)*132 23 12 12 
BIRZIT 190 (190/1150)*132 36 78 78 
AlMAKHFYA 200 (200/1150)*132 34 34 34 
QYSEEN 150 (150/1150)*132 34 22 22 
Total 1150  342   
 
3.4. Data collection procedure 
 
Data were collected using questionnaires and by reviewing the antenatal care follow up 
files of each pregnant woman who gave their consent to participate in the study. 
 
The questionnaire include five groups of participants‟ characteristics, namely: personal 
data, socio-demographic, health state and life style, obstetric and dietary data . Following 
an interview, on the same day, the antenatal care file of each pregnant woman was 
reviewed to obtain information about blood haemoglobin of the mother and review the 
health state. IDA in pregnant women according to the WHO description is based on the 
haemoglobin parameter (who 2016) therefore, in this study, only the haemoglobin and 
MCV parameters were used to determine IDA in pregnant women.  
 
The inclusion criteria included having health records in the antenatal healthcare clinics. 
The exclusion criteria include having a recorded disease associated with anemia such as 
thalassemia minor and sickle-cell disease (SCD). Also  women with the following pre-
pregnancy conditions , kidney, liver, heart, pulmonary, and endocrine diseases; infectious 
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diseases, high blood pressure; diabetes Mellitus , obstetric diseases, such as preeclampsia 
and bleeding.  Receiving or donating blood during pregnancy, and preterm birth (less than 
37 weeks) were excluded. The confidentiality of the subjects were considered and the 
individuals‟ names were not mentioned. 
Using WHO criteria, pregnant women whose haemoglobin level  between 11-15.5 g/dl  
were considered  as control (non-anaemic) and those with a haemoglobin level below 11 
g/dl were selected as case (anaemic), (WHO, 2016). Women clinical status and laboratory 
results were rechecked and cross-checked from their follow up history files. The data 
collectors in all health clinics were the researcher, nurses, doctors and nutritionists who 
were trained for one day at each clinic and gathering data was done five days /week. 
 
The dependent variables were serum Haemoglobin level (Hb), Mean Corpuscular Volume 
(MCV). The independent variables were educational level, household income, family size, 
health state, number of prenatal care visits, parity, abortions, pre-pregnancy weight status, 
pregnancy weight status, dietary pattern, and food intake. 
For food consumption, a 3 days food record instrument was used , women were requested 
to record measured foods and beverages as they were consumed throughout the reporting 
three days . 
The pregnant women were given written instructions to help them include details for all 
foods and beverages consumed, such as brand name, preparation method, portion size was 
estimated using measuring cups and spoons and then analysed using super tracker, 2011 
programme. 
3.5. Data analysis 
 
After gathering the data, SPSS software (version 23, SPSS) and statistical analysis were 
performed. Then outcome variables were dichotomized into 1= cases and 0 = controls and 
two steps (Bivariate and Multivariate) logistic regression analysis was implemented. 
Distribution, frequencies, and cross-tabulation were used to find out how the study sample 
was distributed in each variable. To investigate the association between dependent and 
independent variables crude and adjusted odds ratio were computed at 95% confidence 
interval and p-value < 0.05 for statistical significance. 
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T-test was used to compare average values (means) of iron, vit C, protein, carbohydrates, 
fat  and energy  consumption . One way anova test was used to find out the difference in 
mean between different groups with micronutrients and macronutrients intake. Chi-square 
test was used to compare proportions. A level of significance of 5% was used. 
 
3.6. Validity and Reliability testing 
 
The questionnaire was tested for face validity with referral to experts in the field 
(Dieticians, Academics and Statisticians). The pilot testing results was tested for 
Cornbrash‟s α internal consistency factor using SPSS version 23. And it is found to be α > 
0.72 which is acceptable to proceed. 
 
3.7. Ethical considerations 
 
- The research was evaluated and agreed by the Faculty of Public Health and the Ethical 
Committee at al Quds University. 
- Ministry of Health approval to perform the study and collect data in its clinics was also 
taken. 
- The agreement of the pregnant women on the participation in our study, by using the 
(consent form) that include the aim and objective of our study and the pregnant role in 
it. 
- Confidentiality of the results was declared and was used for the research purposes only 
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Chapter Four: Data analysis and Results 
 
In this chapter we will present the analysis ways that were used and the results which include 
the distribution of participants by frequencies and percentages with mean and standard 
deviations. 
 
Also the results of comparing means tests (dependent t-test and ANOVA), chi square test will 
be presented to show the associations between dependent and independent variables. Results 
of binary and multivariate regression will be presented. 
 
4.1. Descriptive analysis  
 
1. Clinics 
Table (4.1): Distribution of participants by clinic 
 
Clinic Frequency 
Percent  of 
participants% 
 Al-RAMEH- HEBRON 60 17.4 
IDNA – HEBRON 48 14.5 
RAMALLAH 74 21.5 
BERZEIT – RAMALLAH 56 16.9 
AL-MAKHFEYAH – NABLUS 60 17.4 
QUSEN – NABLUS 44 12.2 
Total 342 100.0 
 
Table (4.1) shows the distribution of the study participants according to the clinic where they 
receive the health care services, 31.9% of the participants were from Hebron (South), 38.4% 
Ramallah (Central) and 29.6% Nablus (North). 
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Table (4.2): General characteristics of cases and controls 
 
Characteristics Cases (n=171) Controls 
(n=171) 
All participants p-value 
Height (cm)    0.552 
Mean 161.3 161.0 161.2  
SD 3.02 4.62 3.9  
Weight before pregnancy 
(kg) 
   0.858 
Mean 64.9 64.7 64.8  
SD 10.3 10.2 10.3  
Hemoglobin (HB)    0.000* 
Mean 9.7 12.4 11.1  
SD 0.86 0.89 1.7  
Education Years    0.000* 
Mean 12.1 13.9 13.0  
SD 3.2 3.2 3.3  
Current Smoking    0.000* 
Yes 60 (35.1%) 7 (4.1%) 67 (19.6%)  
No 111 (64.9%) 164 (95.9%) 275 (80.4%)  
Gestational age    0.516 
1
st
 trimester 72 (42.1%) 78 (45.6%) 150 (43.8%)  
3
rd
 trimester 99 (57.9%) 93 (54.4%) 192 (56.2%)  
*Significance at p≤0.05 
 
Table (4.2) shows that Three hundred forty tow pregnant women with 171 cases and 171 
controls were recruited in this study. The response rate was 100%. Of the total population of 
the study 43.8% were in the First trimester of the pregnancy and 56.2% were in third trimester, 
the second trimester pregnant women were excluded from the study as the different case 
definition of anemia (Hb less than 10.5 g/dl) and the least prevalence of anemia at this stage of 
pregnancy. 
 
 The mean of participants‟ weight before pregnancy was (64.8 kg )for all participants, (64.7) 
kg for controls, and (64.9 kg) for anemic cases. The mean of participants‟ height was (161.2 
cm) for all participants, (161.0 cm) for controls, and (161.3) cm for anemic cases. The mean of 
hemoglobin for the total population of the study was (11.1) g/dL with (9.7) g/dL for cases and 
(12.4) g/dl for controls. The average hemoglobin and education years, of the case group were 
all significantly lower than those in the control group (p < 0.05). It was found that (35.1%) of 
the cases were smoker in pregnancy while only (4.1%) of controls were smoker during 
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pregnancy   that means that smoking is significantly and positively associated with IDA, (p < 
0.05). 
 
Table (4.3): Socio-demographic Characteristics of cases and controls 
 
Characteristics Cases (n=171) 
N(%) 
Controls 
(n=171) 
N(%) 
All participants 
N(%) 
p-value 
Residence Place    0.365 
City 112 (65.5) 116 (67.8) 228 (66.7)  
Village 59 (34.5) 55 (32.2) 114 (33.3)  
Number of family 
members 
   0.000* 
2-5 members 87 (50.9) 127 (74.3) 214 (62.6)  
6-10 members 78 (45.6) 39 (22.8) 117 (34.2)  
>10 members 5 (2.9%) 5 (2.9) 10 (2.9)  
Occupation    0.000* 
Working 54 (31.6) 107 (62.6) 161 (47.1)  
Not working 117 (68.4) 63 (36.8) 180 (52.6)  
Monthly income (sheikel)    0.000* 
<1000 sheikel 9 (5.3) 10 (5.8) 19 (5.6)  
1000-3000 sheikel 90 (52.6) 43 (25.1) 133 (38.9)  
>3000 sheikel 72 (42.1) 118 (69.0) 190 (55.6)  
Type of household    0.000* 
Ownership 89 (52.0) 138 (80.7) 227 (66.4)  
Rented 82 (48.0) 30 (17.5) 112 (32.7)  
Having health insurance    0.116 
Yes 76.0 (76.0) 140 (81.9) 270 (78.9)  
No 24.0 (24.0) 31 (18.1) 72 (21.1)  
*Significance at p≤0.05 
Out of 342 participants, 228 (65%) lived in the urban area (city), and 114 (33.3%) were from 
rural areas (villages), residency place is not significant with IDA ,health insurance also shows 
no significant difference between cases and controls . Most of the controls (80.7%) own their 
home but only (52%) of the cases and that show negative association with IDA (p=0.000) and 
about (52.6%) were housewives by occupation. 
Most of the case group average monthly family income 1000- 3000 Shekel (52.6%) compared 
to the control group (25.1%) with statistical difference (p-value 0.000). Also smoker 
participants were more likely to get anemia by OR=8.833 times (CI: 3.925-19.881) which was 
statistically significant (p=0.000) 
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Table (4.4) :  Some medical characteristics of cases and controls 
Characteristics Cases (n=171) 
N(%) 
Controls (n=171) 
N(%) 
All participants 
N(%) 
History of anemia in previous 
pregnancy 
   
Yes 98 (57.3) 36 (21.1) 134 (39.2) 
No 73 (42.7) 135 (78.9) 208 (60.8) 
Type of iron treatment for current 
Anemia 
   
Iron tablets 163 (95.3) …..  
Iron by injection 5 (2.9) .....  
Iron tablet intake/day    
One tablet/day 19 (11.1) 26 (15.2) 45 (13.2) 
Two tablets/day 132 (77.2) 9 (5.3) 141 (41.2) 
Three tablets/day 18 (10.5) -- 18 (5.3) 
Regularity of iron supplement 
intake 
   
Yes 67 (39.2) 149 (87.1) 216 (63.2) 
No 102 (59.6) 20 (11.7) 122 (35.7) 
Reasons of irregularity of iron 
supplement intake 
   
Forgetfulness 27 (15.8) 13 (7.6) 40 (11.7) 
Causing side effects 35 (20.5) 5 (2.9) 40 (11.7) 
Not convinced  of its importance for 
pregnancy 
5 (2.9) 1 (0.6) 6 (1.8) 
Possible adverse effects on fetus 19 (11.1) 5 (2.9) 19 (5.6) 
No reasons neither do not like to 
intake the iron 
20 (11.7) 13 (7.6) 25 (7.3) 
  Other medications used in 
pregnancy 
   
H2 Receptor Antagonist    
Yes 122 (71.3) 23 (13.5) 145 (42.4) 
No 46 (26.9) 136 (79.5) 182 (53.2) 
Calcium supplement    
Yes 102 (59.6) 32 (18.7) 134 (39.2) 
No 68 (39.8) 131 (76.6) 199 (58.2) 
Levothyroxine    
Yes 13 (7.6) 8 (4.7) 21 (6.1) 
No 155 (90.6) 153 (89.5) 308 (90.1) 
Number of meals/day    
One meal 44 (25.7) 3 (1.8) 47 (13.7) 
2 meals 87 (50.9) 16 (9.4) 103 (30.1) 
3 meals 27 (15.8) 69 (40.4) 96 (28.1) 
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>3 meals 10 (5.8) 82 (48.0) 92 (26.9) 
Apatite to food during pregnancy    
Increase 19 (11.1) 88 (51.5) 107 (31.1) 
Decrease 109 (63.7) 25 (14.6) 134 (39.2) 
No change 40 (23.4) 57 (33.3) 97 (28.4) 
 
Table (4.4)  shows that 57.3 % of the cases were previously diagnosed to have anaemia during 
the previous pregnancy while only 21.1% of the controls were previously diagnosed , and 
95.3% of the cases were used tablet regimen for treatment in different dosage as follow: 
11.1% one tablet/day, 77.2% two tablets/day, and 10.5% three tablets/day. 
 
It is obvious that 59.6% of cases did not take iron tablets supplement regularly due to different 
reasons including: 15.8% due to forgetfulness, 20.5% believing that they cause side effects, 
11.1% reported that they have adverse effects on fetus, 11.7% said no reasons for not taking 
Iron tablets regularly, and only 2.9% of them said that it is not important in pregnancy. 
 
Regarding medications in pregnancy, 71.3% and 13.5% of cases and controls, respectively, 
reported that they were taking H2 Receptor Antagonist, 59.6% and 18.75 were taking calcium 
supplement, and 7.6% and 4.7% were only taking Levothyroxine. 
 
For meal frequency, (76.6% vs. 11.2%) of cases and controls were taking one to two meals per 
day respectively, while 24.6% and 88.4% respectively, were taking more than 3 meals per a 
day. A total of 63.7% of cases reported that the appetite during pregnancy decreased, and on 
the other side only 14.6% of controls experienced this condition. 
Table (4.5): The Hb level among cases, controls and both groups 
 Status N Mean Std. Deviation p. value  
hemoglobin (Hb) Cases 171 9.76 0.860  
Controls 171 12.38 1.24 0.000 
 Both 342 11.10 1.60  
 
Table (4.5) shows that the mean of Hb was 9.8 g/dl among the anemic cases and 12.4 g/dl 
among controls. There is negative association between smoking and IDA. 
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Table (4.6): Health symptoms in relation to iron deficiency anemia among cases and 
controls 
 
 Cases Controls  
Crude Odds Ratio (COR)(CI 
95%) 
 
p-value N % N % 
Dizziness and nausea       
Rarely 23 6.9 121 36.3 0.659 (0.292-1.488) 0.217 
Sometimes/often 147 44.1 42 12.6 1.063 (0.946-1.194)  
Vomiting       
Rarely 30 9.1 127 38.4 0.668 (0.339-1.316 0.163 
Sometimes/often 140 42.3 34 10.3 1.089 (0.447-1.252)  
Anorexia       
Rarely 22 6.6 128 38.6 0.538 (0.231-1.253) 0.106 
Sometimes/often 148 44.6 34 10.2 1.092 (0.973-1.226)  
Pallor of the Face       
Rarely 23 6.9 129 39.0 0.790 (0.357-1.747) 0.363 
Sometimes/often 146 44.1 33 10.0 1.036 (0.921-1.165)  
Constipation       
Rarely 19 5.7 88 26.6 0.734 (0.299-1.802) 0.363 
Sometimes/often 151 45.6 73 22.1 1.037 (0.935-1.151)  
Gastric  pain.       
Rarely 15 4.5 81 24.5 0.974 (0.884-1.073) 0.393 
Sometimes/often 154 46.7 80 24.2 1.304 (0.495-3.432)  
Breathlessness       
Rarely 34 10.3 104 31.4 0.938 (0.803-1.096) 0.266 
Sometimes/often 135 40.8 58 17.5 1.284 (0.704-2.341)  
 
Table (4.6) shows the results of (Chi Square (X
2
) analysis, showing that there is no significant 
relation between the mentioned health symptoms and the anemia status of the studied 
population (p<0.05). 
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Table (4.7) : Crude (COR) and Adjusted Odds Ratio (AOR)(CI 95%)of Association of 
anemia with socio-demographic related factors among the study population. 
Characteristics Cases 
(n=171) 
N(%) 
Controls 
(n=171) 
N(%) 
Crude Odds Ratio 
(COR)(CI 95%) 
p-
value 
Adjusted Odds Ratio 
(AOR)(CI 95%) 
p-value 
Residence Place   0.853 (0.543-1.340)    
City 112 (65.5) 116 
(67.8) 
0.949 (0.817-1.102) 0.283 
0.442 (0.216-0.905) 0.026* 
Village 59 (34.5) 55 (32.2) 1.050(0.688-1.603)  2.263 (1.105-4.637)  
Number of family 
members 
  0.388 (0.245-0.614)    
1-5 members 87 (50.9) 127 
(74.3) 
0.711(0.602-0.838) 0.000* 
0.335 (0.167-0.673 ) 0.002* 
>5 members 5 (2.9%) 5 (2.9) 1.832(1.351-2.486)  2.986 (1.487-5.994)  
Occupation   0.261 (0.167-0.410)    
Working 54 (31.6) 107 
(62.6) 
0.499(0.167-1.410) 0.000* 
0.271(0.116-0.635) 0.003* 
Not working 117 (68.4) 63 (36.8) 1.912(1.514-2.413)  3.690 (1.575-8.644)  
Monthly income 
(sheikel) 
  3.044 (1.946-4.762)    
<3000 sheikel 9 (5.3) 10 (5.8) 1.883(1.440-2.461) 0.000* 1.102 (0.496-2.444) 0.812 
>3000 sheikel 72 (42.1) 118 
(69.0) 
1.044(0.735-1.457)  
0.908 (0.409-2.014)  
Type of household   0.241 (0.145-0.400)    
Ownership 89 (52.0) 138 
(80.7) 
0.648(0.556-0.755) 0.000* 
0.346 (0.166-0.724) 0.005* 
Rented 82 (48.0) 30 (17.5) 2.684(1.841-3.911)  2.887 (1.381-6.038)  
Having health 
insurance 
  0.781 (0.461-1.321)    
Yes 76.0 
(76.0) 
140 
(81.9) 
0.950(0.852-1.059) 0.215 
0.576 (0.263-1.260) 0.167 
No 24.0 
(24.0) 
31 (18.1) 1.216(0.801-1.847)  
1.737 (0.794-3.802)  
Education   2.669 (1.552-4.587)    
School stage 79 (46.2) 48 (28.1) 1.552(1.203-2.002) 0.000* 1.175 (.524-2.636) 0.695 
College and higher 38 (2202) 61 (35.7) 0.581(0.430-0.787)  0.851 (0.379-1.908)  
Smoking   12.750 (5.533-30.484)    
No 111 (64.9) 164 
(59.6) 
0.693 (0.623-0.771) 0.000* 
0.077 (0.024-0.245) 0.000* 
Yes 60 (35.1) 7 (4.1) 8.833 (3.925-19.881)  13.038 (4.079-
41.675) 
 
*Statistically significant p≤0.05, COR crude odd ratio, AOR adjusted odd ratio
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Table (4.7) shows the distribution of participants according to their socio-demographic 
characteristics and their associations with the anemic situation of participants (Chi Square 
(X2) and multivariate regression for the associations of variables. Participants who are 
from village are a little bit more risky for anemia than those were from city.  
 
Participants who had completed only the school education had OR=1.5 times to be 
anemic compared with those continue to college or higher educational level, that is 
education level is negatively associated with IDA. Smoking is highly associated with 
anemia with Odds Ratio (OR) = 8.833 (CI: 3.925-19.881) (P=0.000) for smokers 
compared to non-smokers. Families with less than 3000 shekel  per month are more 
likely to get anemia by 1.8 times in comparison with those with less than 3000 shekel  per 
month and its effect of the monthly income is statistically significant (p=0.000) with 
negative association with IDA. 
 
Women who are not working (housewives) are more likely risky for anemia rather than 
those who are working by 1.9 times and p=0.000 which reflect the statistically significant 
effect of working on protection against anemia. Women from family with more than 5 
members are more likely to be anaemic by 1.8 times, that‟s mean, there is appositive 
association between number of family members and IDA. 
 
Participants who live in a rented houses are more likely to be anemic by OR=2.9 times 
(p=0.005), compared with those own their house.  
Not having health insurance appeared to have an effect on getting anemia by OR=1.7 
times, but this effect is not significant (p= 0.167).  
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Table (4.8) : Crude (COR) and Adjusted Odds Ratio (AOR) of Association of anemia and the gynecological and  obstetrical 
characteristics of cases and controls 
 
Characteristics Cases 
(n=171) 
N(%) 
Controls 
(n=171) 
N(%) 
All 
participants 
N(%) 
Crude Odds Ratio 
(COR)(CI 95%) 
p- 
value 
Adjusted Odds 
Ratio (AOR)(CI 
95%) 
p- 
value 
Current pregnancy order        
1
st
 32 (18.7) 42 (24.6) 74 (21.6) 1 (reference)  1 (reference)  
2
nd
 19 (11.1) 49 (28.7) 68 (19.9) 0.440(0.220-0.879) 0.020* 0.499 (0.072-
3.445) 
0.481 
3
rd
 39 (22.8) 34 (19.9) 73 (21.3) 1.430(0.746-2.741) 0.281 2.243 (1.242-
4.050) 
0.007* 
4
th
 and more 81 (47.3) 44 (25.7) 125 (36.5) 2.242(1.242-4.050) 0.007* 5.100 (2.681-
9.700) 
0.000* 
Period between current 
pregnancy and the 
previous one 
       
<one year 22 (12.9) 15 (8.8) 37 (10.8) 1 (reference)  1 (reference)  
1-2 years 80 (46.8) 26 (15.2) 106 (31.0) 9.538 (4.122-22.071) 0.000* 51.524 (4.438-
598.231 ) 
0.002
* 
2-3 years 31 (18.1) 59 (34.5) 90 (26.3) 2.067 (.903-4.731) 0.000* 11.512(2.817- 
47.041) 
0.001
* 
>3 years 8 (4.7) 33 (19.3) 41 (12.0) 5.723 (2.144-15.274) 0.086 3.909(1.022-
14.955 ) 
0.046
* 
MCH (Mother and Child 
Health Care) center 
regular visits 
       
Yes 86 (50.3) 91 (53.2) 177 (51.8) 1 (reference)  1 (reference)  
No 85 (49.7) 78 (45.6) 163 (47.7) 1.154 (0.752-1.770) 0.512 0.849 (0.306-
2.354) 
0.754 
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Menstrual cycle regularity 
before pregnancy 
       
Yes 131 (76.6) 152 
(88.9) 
283 (82.7) 1 (reference)  1 (reference)  
No 38 (22.2) 9 (5.3) 47 (13.7) 4.134 (1.927-8.866) 0.000* 0.967 (0.157-
5.965) 
0.971 
Length of menses (days)        
1-6 days 99 (8.2) 156 
(29.2) 
255(74.5) 1 (reference)  1 (reference)  
7-10 days 72 (49.7) 15 (62.0) 87 (25.4) 7.625 (4.022-14.453) 0.000* 8.783 (2.605-
29.609) 
0.000* 
Heaviness  of menses        
Light 7 (4.1) 72 (42.1) 79 (23.1) 1 (reference)  1 (reference)  
Moderate 82 (48.0) 92 (53.8) 174 (50.9) 6.545 (3.242-13.215) 0.000* 9.717 (2.635-
35.834) 
0.001* 
Heavy 82 (47.9) 5 (2.9) 88 (25.4) 8.485 (9.702-40.314) 0.000* 71.036 (8.132-
620.486) 
0.000* 
Contraceptive use        
Yes 123 (71.9) 85 (49.7) 208 (60.8) 2.468 (1.574-3.871) 0.000* 2.560 (0.178-
36.901) 
0.490 
No 47 (27.5) 82 (48.0) 129 (37.7) 1 (reference)  1 (reference)  
Type of contraception        
Tablets (pills) 24 (14.0) 15 (8.8) 39 (11.4) 5.000 (1.768-14.144) 0.002* 1.786 (0.396-
8.063) 
0.451 
CT Loop(helix) 80 (46.8) 14 (8.2) 94 (27.5) 12.698 (4.813-33.505) 0.000* 3.771 (0.951-
14.959) 
0.059 
Condom 3 (1.8) 23 (13.5) 26 (7.6) .404 (0.107-1.519) 0.180 0.217 (0.032-
1.454) 
0.115 
Contraceptive injection 14 (8.2) 13 (7.6) 27 (7.9) 2.393 (0.804-7.120) 0.117 1.536 (0.255-
9.252) 
0.639 
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Natural 5 (2.9) 24 (14.0) 29 (8.5) 1 (reference)  1 (reference)  
Gestation age        
1st trimester 72 (21.1) 78 (22.8) 150 (43.9) 1.114 (.726-1.709) 0.621 1.546 (0.443-
5.399) 
0.494 
3rd trimester 99 (28.9) 93 (27.2) 192 (56.1) 1 (reference)  1 (reference)  
*Statistically significant at p≤0.05. 
AOR : adjusted odd ratio 
COR : crude odd ratio  
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Table (4.8) shows the distribution of participants according to the gynecological and 
obstetrical characteristics and the binary regression (Odds Ratio (OR) to show the effect 
of independent variables (gynecological and obstetrical characteristics) on the dependent 
variable (the status of participant (anemic or not anemic). 
 
As can be seen from the table, 125 (36.5%) of the participated women were having 4 
deliveries and more, 47.3. % were considered anemic cases compared to 25.7% non-
anemic women. Parity is positively associated with anemia. 
 
21.6 % of the cases have no previous history of abortions while 66.1% of controls haven‟t 
history of any abortion, 66.1% of cases were with a history of one or two abortions and 
12.3% were three or more, compared with controls whom shows that 28.7% have a 
history of one or two abortion and 3.5% three or more, Recurrent of abortion is positively 
associated with IDA. 
 
It is obvious that 80 (46.8%) of the study participants cases and 26 (15.2%) of controls 
had an age gap of 2 years between the pregnancies, and 33 (19.3%) of controls had >3 
years of age gap, the significance difference appeared in the 1-3 years (p = 0.000). 
 
It was found that controls were regularly visiting the MCH and private specialized doctor 
(91.2% and 45.6%) respectively. Menstrual cycle was regular among 76.6% and 88.9% 
of cases and controls respectively. 49.7% and 62.0% of cases and controls had a 
menstrual cycle with length of 3-6 days respectively, while about 42.1% of cases had a 7-
10 days menses. It was found that menses was more heavy among cases rather than 
controls (47.9% vs. 2.9%) respectively. 123(71.9%) of cases and 85 (49.7%) had a prior 
history of contraceptive use before becoming pregnant. Loop was the common 
contraception method used by cases (46.8%), while condom and natural method were the 
common ways used by controls (13.5% and 14.5%). The majority of both cases and 
controls (29.2% and 22.2%) had used contraceptives for 1-2 years. 
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 The menstrual cycles length is different between cases and controls , for the controls, 
62%  are regular with length of 7-10 days, and  49.7% of participated  cases are regular 
with length 7-10 ,length of menstrual cycle is positively associated with IDA. 
 
It is found that 60.8% of women used contraceptives in different ways: Pills (11.4%), 
Loop (27.4%), Male condoms (7.6%), injection contraceptive (7.9%), and natural way 
(8.5%). Only 10.2% of them were using contraceptives for less than one year and the rest 
were using them for one year and more. A total of 192 (56.1%) of studied women were in 
the third trimester of their pregnancy. 
 
Also the table shows the results of the binary regression (Odds Ratio) to show the effects 
of these characteristics on getting anemia. It is seen from the table that the anemic status 
of pregnant women is associated with: parity of deliveries (OR=2.242, 95)(p=0.007); 
repeated abortion (OR=12.326, 95)(p=0.000); period between current pregnancy and 
previous delivery (OR=5.723, 95%) (p=0.086) among 3 years and more group but the 
significance difference appeared in the 1-3 years (p=0.000); irregular menstrual cycle 
(OR=4.134, 9) (p=0.000); the heaviness of menstrual cycle, moderate and heavy 
(OR=6.545)(p=0.000). Using of contraceptive methods (OR=2.468, 95) (p=0.000) ; type 
of contraception mainly pills (OR =5 ), and loop( OR =12.698). While the other factors 
are not significant. 
 
For the multivariate regression (adjusted logistic regression) of obstetrical and 
gynecological characteristics and their effects on getting anemia among pregnant women. 
Some of these characteristics still have effects like: increase in deliveries times, increase 
in abortion times, increase in period between pregnancies, duration (length) of menstrual 
cycle > 7 days, and increase in heaviness of menstrual cycle. 
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Table (4.9) : Association (binary regression) between some medication and dietary characteristics and anemia in women: 
 
Characteristics Cases 
(n=171) 
N(%) 
Controls 
(n=171) 
N(%) 
Crude Odds Ratio 
(COR)(CI 95%) 
p-
value 
Adjusted Odds Ratio 
(AOR)(CI 95%) 
p-value 
Regularity of iron intake       
Yes 67 (39.2) 149 (87.1) 1 (reference)  1 (reference)  
No 102 (59.6) 20 (11.7) 5.072 (3.226-7.973) 0.000 2.488 (0.659-9.390) 0.179 
Medications       
H2 Receptor Antagonest       
Yes 122 (71.3) 23 (13.5) 1 (reference) 0.000 1 (reference)  
No 46 (26.9) 136 (79.5) 13.99 (7.983-24.535)  0.069 (0.012-0.393) 0.003* 
Calcium supplement       
Yes 102 (59.6) 32 (18.7) 1 (reference) 0.000 1 (reference)  
No 68 (39.8) 131 (76.6) 5.611 (3.414-9.220)  0.178 (0.036-0.892) 0.036* 
Thyroid gland (Levothyroxin)       
Yes 13 (7.6) 8 (4.7) 1 (reference) 0.238 1 (reference)  
No 155 (90.6) 153 (89.5) 1.756 (0.690-4.471)  4.749 (0.386-58.404) 0.224 
Number of meals/day       
One meal 44 (25.7) 3 (1.8) 0.012 (0.033-0.045) 0.000 32.659 (1.648-647.020 ) 0.022* 
2 meals 87 (50.9) 16 (9.4) 0.031 (0.014-0.067) 0.000 8.570 (1.026-71.582 ) 0.047* 
3 meals 27 (15.8) 69 (40.4) 0.327 (0.162-0.663) 0.002 4.444 (0.520-37.973 ) 0.173 
>3 meals 10 (5.8) 82 (48.0) 1 (reference)  1 (reference)  
Apatite change during pregnancy       
Increase 19 (11.1) 88 (51.5) 1 (reference)  1 (reference)  
Decrease 109 (63.7) 25 (14.6) 0.057 (0.030-0.108) 0.000 0.759 (0.099-5.835 ) 0.791 
No change 40 (23.4) 57 (33.3) 0.348 (0.190-0.638) 0.001 0.531 (0.062-4.511 ) 0.562 
Total 171(100%) 171(100%)     
*Statistically significant at p≤0.05
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Table (4.9) shows the association between some medication, the appetite and the number 
of meals with IDA. About 58.5% of participants taking oral iron tablets as a medication 
in regular basis (63.2%). Other types of medications were found to be used by 
participants including: H2 Receptor Antagonist (42.4%), Calcium supplements (39.2%), 
and only 6.1% taking treatment for hypothyroidism. 
 
Binary Logistic regression analysis (Odds Ratios (OR)) was carried out to assess the 
possible relationship and the results showed that IDA is significantly negative associated 
with regular intake of iron supplement (COR =5.072, 95% CI =3.226-7.973, p=0.000).  
Positive association between H2 Receptor Antagonist use and IDA (COR=13.99, 95% 
CI=7.983-24.535) (, p= 0.000) is found.   
There is positive association between Calcium supplement and IDA (COR=5.611, 95% 
CI= 3.414-9.220), ( p=0.000). 
 Number of meals per day is negatively associated with IDA (OR=0.327, 95% CI=0.162-
0.663)( p< 0.002),  
 In addition, increase in appetite during pregnancy is negatively associated with IDA 
(OR=0.348, 95%CI=0.190-0.638), (p,0.001).  
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Table (4.10) : Distribution of participants according to their daily intake of macro 
and micronutrients 
 
 
Status Number Mean 
Std. 
Deviation 
Significance 
P-value 
Macronutrients 
protein intake in gram 
per day 
Case 
171 36.47 10.25 
0.001 
 Control 171 66.62 7.81 
carbohydrates intake 
in gram per day 
Case 171 73.80 16.66 
0.000 
Control 171 136.13 30.91 
fat intake in gram per 
day 
Case 171 32.50 7.92 
0.166 
Control 171 49.43 8.95 
Micronutrients  
iron intake in 
milligram per day 
Case 171 11.62 2.71 
0.000 
Control 171 23.05 5.76 
vitamin C intake in 
milligram per day 
Case 171 58.21 10.67 
0.274 
Control 171 74.21 10.27 
Total energy intake in kilo calorie per day 
 Case 733.6 Kcal 
Control 1255.9 Kcal 
 
Table (4.10) shows that the means of all macronutrients and micronutrients (protein, 
carbohydrates, fat, iron, and vitamin C) daily intake by participants are less in the cases 
than controls. The means of these nutrients (protein g/ dl, carbohydrates g /dl, fat g/ dl , 
iron mg/ dl, and vitamin C mg/ dl ) were 36.5, 73.8, 32.5, 11.6, and 58.2 among cases 
respectively. There are significant differences in means of these nutrients intak between 
cases and controls. It seems that controls were taking these nutrients in higher amounts 
than the cases as 66.6, 136.1, 49.4, 23.1, 74.2, respectively, 
Anemic women were also suffering from lower daily energy intake compared by 
controls. 
*1gram of protein= 4 kcal, 1gm of carbohydrates= 4 k cal , 1 gm of fats=9 k cal  
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Table (4.11) : The odds ratio (OR) for daily intakes of macro and micronutrients 
 
Hb Sig. 
P-value 
Odd 
Ratio 
(OR) 
95% Confidence Interval for 
OR 
Lower 
Bound 
Upper 
Bound 
Controls      
protein intake 0.000 1.128 1.067 1.192 
carbohydrates 
intake 
0.062 1.017 .999 1.036 
fat intake 0.061 1.055 .998 1.116 
iron intake 0.048 1.129 1.001 1.274 
Vitamin C Intake 0.013 1.060 1.012 1.111 
 
Table (4.11) shows that the association between protein, iron, and vitamin C , and 
anemia (OR: 1.128, 129,1.060,respectively), )( p< 0.005) is  negatively statistically 
significant. 
 Participants‟ fat and carbohydrates intake are weakly associated. (OR: 1.055, 1.017 
respectively), (p = 0.062). 
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Table( 4.12) : Results of one way ANOVA for the association of taking 
micronutrients and anemia 
ANOVA Table 
   Sum of 
Squares 
Df 
 
Mean 
Square 
 
F Sig. 
p-value 
HB level * protein 
intake in gm per day 
Between 
Groups 
 67.7 51 1.328 22.721 0.000* 
Within Groups 16.8 288 .058   
Total 84.5 339    
HB level * 
carbohydrates intake 
in gm per day 
Between 
Groups 
 60.8 69 .882 10.041 0.000* 
Within Groups 23.7 270 .088   
Total 84.5 339    
HB level * fat intake 
in gm per day 
Between 
Groups 
 41.9 41 1.022 7.141 0.000* 
Within Groups 42.6 298 .143   
Total 84.5 339    
HB level * iron intake 
in mg per day 
Between 
Groups 
 64.6 24 2.694 42.579 0.000* 
Within Groups 19.9 315 .063   
Total 84.5 339    
HB level * vitamin C 
intake in mg per day 
Between 
Groups 
 37.8 46 .823 5.159 0.000* 
Within Groups 46.7 293 .159   
Total 84.5 339    
 
Table (4.12) shows the differences between the groups (the anemic and the 
nonanemic ) to assess the association between IDA and the intake of these ingredients 
The associations are all statistically significant (p-value 0.000) 
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Chapter Five: Discussion 
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5. Discussion of results 
 
Iron deficiency anaemia (IDA) among pregnant women in the Palestinian population 
is a public health problem, it  might be associated with several factors such as, genetic 
factors, inadequate health care, malnutrition or bad habit, low socioeconomically 
status,  or might be due to lack of knowledge and awareness ( Addis et al ,2014 
,Abdelrahman et al,2012). 
This study is aimed to analyze the underlying nutritional risk factors and the 
sociodemographic factors that may affect this health problem. 
 
5.1. Socio demographic and economic factors 
 
It is observed that among anaemic participants pregnant women, (26.9%) had mild 
anaemia, (22.8%) had moderate anaemia, and none had severe anaemia. 
The average of (Hb) and education years of the case group were all significantly 
lower than those in the control group, the prevalence of severe anaemia is expected to 
be more in the less educated group . A study done by Rohra and his colleagues 
speculates that adverse haemoglobin status of pregnant women attending public sector 
hospital might be due to the socioeconomic status as well as low level of education 
(Rohra et al ,2008) , Another study was  done by Hyder in Bangladesh concluded that 
56% of the pregnant women had attended school for at least a year (Hyder et al, 2013) 
Smoker participants were risky and more likely to get anemia by OR=8.833 times 
(CI: 3.925-19.881) which was statistically significant (p=0.000) ,the link between 
tobacco use and iron deficiency anemia is found in our current study and elsewhere ( 
Chelchowska et al 2016),( Subramoney et al 2008). 
Although this study was not designed to determine the prevalence of smoking among 
pregnant women, but to our knowledge, there have been no previous studies 
evaluating the prevalence of smoking in pregnant women in the West Bank or its 
effect . However, the high prevalence of current smoking in our study sample 
indicates the need to develop prevalence studies and plans for smoking cessation 
programs during pregnancy. 
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According to data from the literature, pregnancy promotes smoking cessation, and  
many of the smokers and former smokers did not know that smoking cessation 
treatment was available.( Fontanella et al 2012) Furthermore, it is reported that 
mothers feel guilty about smoking during pregnancy ( Fontanella et al 2012 ). 
Therefore, considering smoking cessation and treatment before or during pregnancy 
could be effective tools. 
 
Most of the cases average monthly family income falls below 3000 Israeli Sheikel 
(52.6%) compared to the control group (25.1%) with statistical difference ( p-value 
0.000.). 
The evidences have been shown from the survey conducted in 2008, which revealed 
that West Bank households‟ poverty rates were (48%), that affect the life style and 
quality and quantity of food (WHO 2009). 
A number of researchers have reported that the high  prevalence of IDA  occur among 
people living in chronic poverty (Sharma et al ,2003). 
IDA among women from the lower monthly income families in our study and in any 
other studies  is may explained in part by the fact that heme iron is almost absent from 
their diets  or even not taking the iron supplement , The results of this study showed 
that anemia is significantly  negative associated with regular intake of iron 
supplement  (COR =5.072, 95% CI =3.226-7.973, p=0.000),it is the same as result of 
many other studies which showed significant association between IDA and 
irregularity of iron supplement and poor diet, 
(Gupta et al , 2013 ,  Mayo Clinic, 2016 , Taylor et al ,2015) 
 
In respect to the number of children, it is clear from the data that most women were 
more likely to have many children, Women from family with more than 5 members 
are more likely to be anaemic by 1.8 times.  A study in Kisumu, Western Kenya result 
in the fact that prevalence of anemia was higher in women with family size >7 
compared to their counterparts (Jemal et al 2009) 
It may be explained that the women of the lower social class are more likely to 
develop IDA during pregnancy, because they are: 1) less aware of adequate diet 
during pregnancy, 2) more likely to have multiple pregnancies, 3) reluctant to use 
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contraceptives and keep an appropriate interval between pregnancies, and 4) less 
likely to take iron tablets for prophylactic purposes. 
5.2. Gynaecological and obstetrical factors 
 
In this study  , maternity and obstetric characteristics play a significant role in IDA 
during  pregnancy. i.e. increased  parity  , increased  abortion times mainly more than 
three, and the  period between pregnancies. 
Multi-parity: 
IDA of pregnant women is associated positively with parity of deliveries (OR=2.242), 
women with more than 4 pregnancies are 2,2 more chance  to be affected. 
This finding is consistent with the study done in Turkey in which pregnant women 
with parity of four or more were 2.2 times more anemic compared to those with parity 
less than four (Karaoglu et al 2010) . Multiparty may induce IDA by reducing 
maternal iron reserves at every pregnancy and by causing  blood loss at each delivery, 
Primiparous pregnancies were found to be at a higher risk of IDA compared to 
pregnancies with parity of 1 to 2  (Delpisheh et al 2006).  
 
Use of contraception: 
In this study, pills and loop (helix) were strongly associated with IDA development, 
the length of menstrual cycle of  > 7 days, and increased density  of menstrual cycle 
were also positively associated with the development of IDA . 
Oral contraceptive pills (OCP) and loops ( helix )  generally cause  heavy and 
irregular menses which lead to IDA (WHO, 2016). Hormonal contraceptives like 
OCP have its risk of menorrhagia and irregular menses  and so more IDA than others 
kinds of contraception (ACOG ,2008). 
 
Haile and his colleagues (2016)  showed that the prevalence of  IDA in OCP users 
was lower than that  in our population , but  they used  haemoglobin < 12 g/dl to 
define anaemia, and the  Iron status is vary with the type of OC used. the progestin 
generation pills  is associated with high ferritin concentration and the fourth-
generation pills that has ant androgen activity results in a lower intermenstrual 
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bleeding effect and they are not common used in our primary care clinics . This 
finding probably explains the difference. 
 
Child spacing 
It is obvious from the result of the study that the cases mainly apart 1-2 years in 
between pregnancies, but controls apart mainly 2-3 years duration, which has been 
shown to be negatively associated with IDA.  The possible reason could be that child 
spacing minimizes bleeding during delivery and give a time for more self-care and 
easily to get the demand of iron for the mother body only rather than the mother and 
her foetus and enhances iron reserve in the body, limiting of births or using family 
planning to control and space births is a key contributing factor to the prevention of 
anaemia during pregnancy. 
Having too many under five children or too frequent birth is among the key predictors 
of anemia in Ethiopia identified by the current analyses. This is also consistent with 
the findings of other studies (Abriha et al , 2014, Gebremedhin et al ,2011) 
Many studies reflected that most of the anemic pregnant women were multi gravida 
and less child spacing and so, multiparty and short birth spacing may lead to anemia 
in women (Woldemariam et al, 2002) 
 
 
Abortion 
From the results, it has been shown that recurrent abortions (more than 3and even 2) 
were strongly associated with IDA , which is consistent with guidelines and 
consideration   (WHO ,2016 , ACOG, 2008). 
An old study done in India resulted in negative association between abortions and 
IDA , this is an old study , the methodology , the tools of analysis  or may  the social 
stigma attached to abortion at that time had limited the number and/or types of 
abortions reported and so results in that. Despite this, there was a positive correlation 
between the number of spontaneous abortions and the likelihood of developing 
anaemia at final HB reading (Prema, 1979). 
The prevalence of anemia was seen to be increased with the number of abortion where 
the probability of being anemic among women‟s who had history of abortion was 5 
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times more likely to be higher than who had no history of abortion and this could be 
resulted because abortion exposes women to loss of more blood and might expose 
them to periods of hemorrhage which depletes body stores of iron that leads to extra 
requirement of iron than usual (Tadesse et al, 2017) 
Many studies showed that women who experienced abortion or terminated pregnancy 
before the index pregnancy were found to have a 2.63 times higher risk of developing 
anemia than those who did not ( Uche et al ,2010, Wiebe at al ,2006) 
 
Anti-acid medications usage during pregnancy 
In this study ,there is positive association between the anti-acid medications usage 
during pregnancy  and development of IDA ,  it is well documented that antacids have 
been shown to reduce the absorption of iron ,also patients taking antacids for digestive 
complaints may prove to have gastrointestinal disease and that all is related to IDA ,( 
Kepczyk et al , 1999). 
A study in Journal of Internal Medicine, used data from more than 50,000 patients and 
showed that continuous anti acid, increased the risk of iron deficiency. People using 
one tablet of 20 mg anti acid or more daily had a higher risk of iron deficiency 
compared with people using less than one tablet daily (Tran et al, 2018) 
 
5.3. Nutritional factors 
 
Dietary iron is found in a variety of foods, seafood, green leafy vegetables, dark 
chocolate, beef liver, and nuts, also ,iron-fortified foods include cereal and most other 
grain products, , but iron is particularly high in red meats and so, meats regulations 
are implemented by the Food and Drug Administration (FDA). People who consume 
diets with little to no intake of meats or iron-fortified foods, such as vegans and 
vegetarians, have a great need for any other sources of iron (National Institutes of 
Health, 2015) 
In this study most of the cases  were taking iron tablets for treating anaemia, in 
different dosage as follow: 11.1% one tablet/day, 77.2% two tablets/day, and 10.5% 
three tablets/day, and this means that there is no problem in compliance which  has 
lead us to think in another causes such as the nutrition . There is no significant 
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difference between the cases and the controls in (Dizziness, nausea, vomiting , pallor, 
dyspnoea or constipation) symptoms in the studied population ,But anaemic women 
had 1.3 times more to suffer from stomach pain, and 1.2 times from Anorexia. This is 
might be because these are the most tow common symptoms occur in the first and 
third trimester. There are more than 60 studies in meta-analysis on the use of iron 
supplements in pregnancy. A total of more than 40,000 women took part in the studies 
and the results show that, if women have normal iron levels, taking 30 mg of iron per 
day as a prophylaxis doesn‟t have any noticeable health benefits for them or for their 
children. Although iron supplements were found to lower the risk of anaemia, they 
didn‟t influence the number of preterm births, the number of babies with a low birth 
weight (under 2,500 grams) or infections in pregnant women (Pena-Rosas ,2015). 
 
Calcium 
The recent results showed that IDA is  positively associated with regular intake of 
Calcium supplement , Some studies  in young women have found no effect of calcium 
supplementation on serum ferritin or hemoglobin concentrations  ( Sokoll  et al 
,1992). 
Some studies have investigated whether milk product consumption may impact iron 
absorption. In a randomized crossover trial over 4 days, the consumption of a glass of 
milk with 3 main meals, or the consumption of calcium-fortified foods providing an 
equivalent amount of calcium, did not inhibit nonheme-iron absorption (Grinder, 
2004), Another study,  found that the addition of milk or yogurt to a plant-based diet 
did not affect iron bioavailability (Rosado et al 2005), the calcium in our study is pure 
supplemental and for long term which might cause the observed difference. 
 
Ascorbic acid (vitamin C) 
Vitamin C is protective from IDA with negative association with it , It  has a strong 
iron absorption promoting potential effect. In this study , the effects of   iron, and 
vitamin c intake was protective agent  (OR: 1.129,1.060, respectively) and these 
effects were statistically significant to prevent anaemia. 
 Ascorbic acid supplements or an increased intake of ascorbic acid rich foods could 
have important public health implications on IDA , especially in populations on a 
mainly plant food based diet (Institute of health ,2015). 
56 
 
The main enhancers of non-haem iron absorption are ascorbic acid (WHO, 2015). 
 
Macronutrient  
The means of proteins, carbohydrates, fats,  were 36.5 g, 73.8g, 32.5 g, per day among 
cases, respectively. There were significance differences in means of these nutrients 
intake (except fat) between cases and controls.  
The result has been shown that there are effects of protein, iron, and vitamin c intake 
for not getting anemia (OR: 1.128, 129, 1.060), respectively (p< 0.005) and these 
effects are negatively associated and statistically significant. 
 Participants‟ fat and carbohydrates intake are not enough to protect from getting 
anemia. (OR: 1.055, 1.017 respectively), ( p  =0.062 ). 
 The effects of protein were statistically significant as protective agent from IDA.  
Protein is one of the iron absorption enhancer as shown in sharma et al whom 
conclude that Iron absorption can be increased by enhancers (haem, proteins, ascorbic 
acid and fermentation) and decreased by inhibitors (phytic acid, fibres, calcium, 
tannins, tea, coffee, chocolate and herbal infusion) ,(Sharma et al , 2003). 
The evidence showed that dietary factors such as low consumption of red meat, 
vegetables, cereals and fruits have been reported to be associated with IDA.( Institute 
of health ,2015). 
Literature also revealed that consumption of heme iron rich food sources (chicken) 
were associated with lower prevalence of anemia (  Belachew et al 2006)   . This 
could be because chicken is a rich source of heme iron, which is highly bioavailable 
and has an enhancing effect on non-heme iron absorption and that reflect the negative 
association between protein and IDA (  Belachew et al 2006)     
An intervention study  investigating the effect of adding protein or phytate (in the 
form of soy protein) ,It is  found that serum ferritin concentrations increased when 
women consumed either 40 g of soy protein isolate or whey protein per day as a meal 
replacement over a 24 week period(Swain et al 2002). 
 Inadequate intake of chicken as source of protein and heame iron, may increase the 
occurrence of IDA (Monsen et al 1982).  
 WHO stated that in developing countries inadequate intake of dietary iron is the main 
causes of anemia during pregnancy (De Benoist 2005). 
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The results of this study are compatible with the WHO diet recommendations for the 
IDA patients. 
WHO recommendation for diet for IDA adult (who, 2016): 
1- High protein and low carbohydrates diet. 
2- Getting adequate daily protein from meat, soy or plant food combinations such as 
beans or lentils with rice. 
3- Reduce or eliminate refined sugar from the diet. 
4- Small amounts of honey or molasses are allowed. 
5-   Cut the complex carbs (whole grains) from the diet. 
6- The iron in fruits and vegetables is not easily absorbed, these food items are 
essential for nutrients such as vitamin which is enhancer for iron absorption. 
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Chapter Six: Conclusion and Recommendations 
  
59 
 
6.1. Conclusion 
 
This study is consistent and correlated with many others studies in addressing the 
association between socio-demographic, gynaecological and obstetrical factors . 
The nutritional factors mainly the negative association of iron, vitamin  , protein with 
IDA in pregnancy was the main conclusion  
 
It is observed that the some of the aetiologies of iron deficiency remains the same 
over the decades. i.e. multiparty, short birth spacing, poor socio economic status. Lack 
of education about the effect of the nutritional factors and the bad dietary habits  is 
responsible for high prevalence of IDA in pregnancy in West –Bank . 
 
The prevention of IDA in pregnant women depend on the level of knowledge about 
nutritional factors that may associates with IDA , early and successful utilization of 
iron supplementation ,diagnostic tools and treatment options. 
 
It is not only needed to prevent anaemia by supplementation but also to address the 
nutritional factors, the socio-economic and cultural factors associated with it . All of 
these factors should be enhanced in line with the Millennium Development  Goals 
.These goals include eradicating extreme poverty, reducing child mortality rates, 
improving maternal health, fighting disease and epidemic, and developing a global 
partnership for development and they all will help to prevent anaemia in pregnancy 
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6.2. Recommendation 
 
 -For MoH  : 
1- To continue its strategy in IDA prevention and treatment and to introduce a 
comprehensive health education program through patient counselling, and more 
nutritional education to raise awareness among IDA pregnant women. 
2- Create integration between clinics and hospitals systems for better management of 
IDA pregnant and to know the exact outcome on the lady and her baby.  It is also 
important to ensure completeness of patient files . 
3- Implementation of health promotion program targeted the pregnant women and 
their families about nutritional iron deficiency anaemia.  
  
 -For future research  : 
1- Longitudinal studies in depth to study the cause-effect relationship between the 
nutritional factors and IDA.. This could be useful for decision makers to plan properly 
for IDA in Palestine  
2- Further research and individualized education about nutrition and its crucial 
association with IDA in pregnancy is necessary.   
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6.3. Limitations 
 
 
In this study Hb and MCV level were used to diagnose anaemia instead of using 
Ferritin level based on studies conducted by WHO. 
The time and unavailability of fund were important limitations 
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8. APPENDICIES 
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 eriannoitseuQ ehT :1 xidneppA
 
 
 
 
أزػ٘ حؼطاتنِ  ,جبٍؼٔ اىقسغ –ٍِ مئٍ اىظحٔ اىؼبٍٔ  نيفين وجيه الشلالفهأّب اىجبحخٔ 
اىؼ٘اٍو اىتغصٌٗٔ اىتى قس تؤزي اىى فقط اىسً فً اىؽٍسات (ثؼْ٘اُ   ىيَشبضمٔ فً ٕصٓ اىسضاؼٔ
ّٗؤمس ىل اُ ٕصٓ اىسضاؼٔ ػئٍَ ,ٍِ ذلاه تؼجئٔ الاؼتجٍبُ اىَطفق ) اىح٘اٍو فً اىؼفٔ اىغطثٍٔ
ٗؼ٘ف ٌتٌ اىتؼبٍو ٍغ اىَؼيٍ٘بت ثؽطٌٔ تبٍٔ ٗىِ تتٌ ٍشبضمتٖب ٍغ أي شرض أٗ اؼترساٍٖب 
 .ثشنو شرظى 
ٗاُ اذتطتِ اىَشبضمٔ ٌطجى الاجبثٔ , اىَشبضمٔ ؽ٘ػٍٔ ثشنو مبٍو ٗثبٍنبّنِ ضفغ اىَشبضمٔ 
 .ػيى جٍَغ الأؼئئ ثشنو ٗاػح ٗزقٍق 
 
   :ؼٍتٌ تؼجئٔ ٕصا اىجعء ٍِ قجو اىجبحخٔ 
 )ؼٌ (٘ه اىط 
مغٌ ( قجو  اىحَو    اى٘ظُ 
 )
 )مغٌ (اى٘ظُ اىحبىً  
ػَط اىحَو اىحبىً  
 )أؼج٘ع (
 
 
 
 18
 
 :القسن الأول 
 :هعلوهات عاهه عن الوشاركه 
 )..........................................اذتٍبضي (الاؼٌ  -1
 ..............................................تبضٌد اىٍَلاز  -2
 ٍرٌٍ -3قطٌٔ              -2ٍسٌْٔ            -1ُ اىؽنِ              ٍنب -3
 )...............اذتٍبضي(ضقٌ اىٖبتف  -4
 :القسن الثاني
 :هعلوهات اقتصاديه واجتواعيه 
 ػسز أفطاز الأؼطٓ اىَت٘اجسٌِ فً اىَْعه -1
 أفطاز 5-2 -1
 أفطاز 11-6 -2
 11أمخط ٍِ  -3
 
 لا تؼَو  -2...................           .......ٍبٕ٘ ػَيل , تؼَو  -1اىَْٖٔ ؟؟   -2
 
 )ثبىشٍنو (زذو الأؼطٓ الاجَبىى  -3
 1111أقو ٍِ  -1
 1113 – 1111ٍِ  -2
 1113أمخط ٍِ  -3
 اٌجبض -2ٍيل                     -1ّ٘ع اىؽنِ اىحبىى               -4
 
 ؼْٔ .................... ؟) اىَسضؼٔ ٍٗب ثؼسٕب (ػسز ؼْ٘ات اىسضاؼٔ  -5
 :لث القسن الثا
 :نوط الحياه والحاله الصحيه العاهه 
 لا-2ّؼٌ                        -1ٕو ىسٌل تبٍٍِ طحً                 -1
 
 ثفقط زً اىحسٌس فً اي حَو ؼبثق ؟)ػِ ؽطٌق اىطجٍت (  ٕو تٌ تشرظٍل  -2
 ّؼٌ-1
 لا -2
 
-1    ٕو أذجطك اىطجٍت أٗ اىََطػٔ ثأّل تؼبٍِّ ٍِ فقط زً اىحسٌس فً ٕصا اىحَو ؟؟ -3
 لا -2  ّؼٌ          
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ٌَنِ اذتٍبض (ٍبًٕ ذطٔ اىؼلاد اىتى تتجؼٍْٖب؟, ػِ اىؽؤاه اىربٍػ ثْؼٌ   فً حبه الاجبثٔ-6    
 )أمخط ٍِ اجبثٔ
 حٍَٔ غصائٍٔ -1
 أزٌٗٔ -2
 
 اشا مْت تتجؼٍِ ػلاجب زٗائٍب فَب ّ٘ػٔ ؟_ 6
 أقطاص اىحسٌس  -1
 اىحسٌس ػِ ؽطٌق اى٘ضٌس  -2
 تأذصٌْٖب؟ىتى اىقطاص فَب ػسز الأ) أقطاص اىحسٌس(سٗائىاشا مْت تتجؼٍِ اىؼلاد اى -7
 ٗاحسٓ ٌٍٍ٘ب -1
 احْتبُ ٌٍٍ٘ب  -2
  .ٌٍٍ٘بٔ أقطاص حلاح -1
 لا  -2ّؼٌ                            -1ثبّتظبً ؟   فً اىحَو اىحبىً ٕو تتْبٗىٍِ أقطاص اىحسٌس -8
 )َنِ اذتٍبض أمخط ٍِ اجبثٔ ٌ(اشا مبّت الاجبثٔ لا  فَب ٕ٘ اىؽجت ىؼسً تْبٗىل اقطاص اىحسٌس؟-9
 اىْؽٍبُ -1
 الاٍؽبك اٗ اىٌ اىَؼسٓ خولاّٖب تؽجت أػطاع جبّجٍٔ ٍعػجٔ ٍ -2
 اّت غٍط ٍقتْؼٔ اّٖب ٍَٖٔ فً اىحَو  -3
 اىجٍِْ  ىذ٘فب ٍِ اُ ٌنُ٘ ىٖب تأحٍط ػي -4
 لا ٌ٘جس ؼجت ٍحسز ىنِ لا احت اذص اي ازٌٗٔ-5
 
  ٕو تأذصٌِ أي ٍِ الأزٌٗٔ اىتبىٍٔ ثشنو ٍعٍِ ؟-11
 ).ؼتقً٘ اىجبحخٔ ثَؽبػستل ىلاجبثٔ ػِ ٕصا اىؽؤاه ( 
 لا ّؼٌ اىسٗاء
  ازٌٗٔ ٍؼبزات اىحَ٘ػٔ
 ROTPECER 2H
 TSENOGATNA
  
   ٍقٌ٘بت اىنبىؽًٍ٘
 ازٌٗٔ ّشبؽ اىغسٓ اىسضقٍٔ
 NIXORYHTOVEL
  
 
 لا -2ّؼٌ                        -1:   حبىٍب ) ٍئجاىؽجبئط أٗ الأض(ٕو تسذٍِْ  -11 
 :فً حبه الاجبثٔ ثْؼٌ 
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 فً اىًٍ٘ ؟...........أزذِ ؼجبئط ثَؼسه 
 أقو ٍِ ػيجٔ -1
 ػيت 3-1 -2
 .ػيت 3أمخط ٍِ  -3
 ضأغ فً الاؼج٘ع ؟.........ٍئ ثَؼسه جأزذِ الأض        
  2-1 -1
 4-3 -2
 .أٗ أمخط  5 -3
 لا -2ّؼٌ                    -1 ٕو مْت تسذٍِْ ؼبثقب؟        -21        
 ْص ٍتى تطمت اىتسذٍِ ؟ٍ-31         
 أقو ٍِ ؼت شٖ٘ض -1
 شٖط 11اىى  شٖ٘ض 6ٍِ  -2
 ؼْ٘ات  3ٍِ ؼْٔ اىى  -3
 ؼْ٘ات  3ٍِ أمخط  -4
 ٍْص ثسأٌ اىحَو اىحبىى  -5
 مٌ ٍؼسه ؼبػبت ٍّ٘ل ؟-41         
 ؼبػبت  4أقو ٍِ  -1
 ؼبػبت  6 -4ٍِ  -2
 ؼبػبت  8 -7ٍِ  -3
 ؼبػبت  8أمخط ٍِ  -4
 : زابعالقسن ال
 الصحه الانجابيه
 ؟اىحبىً  اىحَو ت تطتٍٕ٘ ٍب  -1
 الاٗه -2
 اىخبًّ -3
 اىخبىج -4
 اىطاثغ -5
 اىربٍػ -6
 5أمخط ٍِ  -7
 
الاجٖبع ٕ٘ فقساُ اىحَو  ثؼَط أقو أٗ (مٌ ػسز الاجٖبػبت اىتى تؼطػت ىٖب ؟ -2
 )اؼج٘ع  42 ٌؽبٗي
 ىٌ اتؼطع لأي اجٖبع  -1
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 2 -2
 3 -3
 أمخط ٍِ حلاحٔ  -4
 
 اشا ىٌ ٌنِ ٕصا حَيل الاٗه فَب ًٕ اىفتطٓ ٍب ثٍِ اىحَو اىؽبثق ٕٗصا اىحَو ؟ -3
 أقو ٍِ ؼْٔ-1
 ؼْٔ  2-1-2
 ؼْ٘ات 3-2 -1
 ؼْ٘ات  3أمخط ٍِ -4
 
 لا  -2ّؼٌ          -1ٕو تؼبٍِّ ٍِ ّعٌف ٍٖجيً فً اىحَو اىحبىً ؟   -4
 
فً  xى ػؼ(تؼبٍِّ ٍِ أي ٍِ ٕصٓ الاػطاع احْبء اىحَو اىحبىً ػبٍّت أٗ  ٕو  -5
 )َنبُ اىَْبؼتاى
 غبىجب أحٍبّب ّبزضا اىؼطع اىَطػى
    اىسٗذٔ ٗاىغخٍبُ
    اىتقٍؤ
    فقساُ اىشٍٖٔ
    شح٘ة اى٘جٔ
    الاٍؽبك
    أىٌ فً اىَؼسٓ
    ػٍق اىتْفػ 
 
 لا  -2ّؼٌ                   -1ٕو تطاجؼٍِ ٍطمع الاٍٍ٘ٔ ٗاىطف٘ىٔ ثبّتظبً ؟   -6
 
 ثٔ لا فٖو تطاجؼٍِ ؽجٍت ٍرتض ثبىحَو ٗاى٘لازٓ فً اىقطبع اىربص ؟اشا مبّت الاجب -7
  لا  -2ّؼٌ                                      -1
 
 لا -2ّؼٌ                                   -1ٕو اىسٗضٓ اىشٖطٌٔ ٍْتظَٔ ؟    -8
 
 مٌ ػسز اٌبً اىسٗضٓ اىشٖطٌٔ ؟ -9
 اٌبً  3أقو ٍِ  -1
 أٌبً  6-3 -2
 أٌبً  11-7 -3
 ٍِ شىل  أمخط -4
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 تؼتجط زٗضتل اىشٖطٌٔ ؟ -11
 ذفٍفٔ -1
 ٍت٘ؼطٔ -2
 حقٍئ -3
 حقٍئ جسا  -4
 
-2ّؼٌ               -1؟   قجو اىحَو اىحبىً  ٍ٘اّغ اىحَو ت أ ي ٍِاؼترسٍ ٕو -11
 لا 
 
 اشا مبّت الاجبثٔ ّؼٌ  فَب ًٕ اى٘ؼٍئ اىتى تٌ اؼترساٍٖب ؟ -21
 اقطاص ٍْغ اىحَو  -1
 اىي٘ىت -2
 اىؼ٘اظه اىَطبؽٍٔ  -3
 و الاثط ٍبّؼٔ اىحَ -4
 ........... ٍخو, غٍط شىل   -5
 
 ؟ٕصا اىَبّغ اؼترسٍت ثٖب  اىتىاىَسٓ اىعٍٍْٔ ى ٍبٕ -31
 أقو ٍِ ؼْٔ  -1
 ؼْٔ 2-1 -2
 ؼْٔ 4-2 -3
 ؼْ٘ات  4أمخط ٍِ  -4
 :الجزء الخاهس 
 :الوعلوهات الغذائيه
حبىٔ ٍِ حبلات الأمو اىتى تنُ٘ فً (اى٘ججٔ ًٕ ,  ٗججبت.............. أتْبٗه ٌٍٍ٘ب  -1
اىْبغ فٍٖب أغصٌٔ تٌ اػسازٕب ٗتجٍٖعٕب ٍخو اىفط٘ض  ظٍِ ٍحسز ٌٗتْبٗه
 )اىؼشبء ,اىغساء,
 ٗججٔ ٗاحسٓ -1
 ٗججتٍِ -2
 ٗججبت 3 -3
 تٗججب 3أمخط ٍِ  -4
 
 ؟ مٍف تتغٍط شٍٖتل ّح٘ الامو فً اىحَو -2
 تعٌس -1
 تْقض -2
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ثنبفٔ أّ٘اع اىطؼبً اىتى تٌ )ثَب فٍٖب ًٌ٘ اىؼطئ (اىطجبء تؼجئٔ اىجسٗه اىَطفق ىَسٓ حلاث أٌبً 
 ),ؼتؽبػسك اىجبحخٔ فً شىل( ؽٍئ اىًٍ٘ ٗمٍَبتٖب تْبٗىٖب
 ......................اىًٍ٘ ..............                                  اىتبضٌد 
. ٍش٘ي(اى٘طف اىنٍَٔ ّ٘ع اىطؼبً  اى٘ججٔ
 )ٍطج٘خ.ٍقيى
    الافطبض
    ٗججٔ ذفٍفٔ
    اىغساء
    ٗججٔ ذفٍفٔ
    اىؼشبء
    ٗججٔ ذفٍفٔ
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 )2 xidneppA(
  ytisrevinU sduQ-lA
    tneduts etaudarG fo pihsnaeD
 htlaeh cilbuP fo loohcS
 
 عنوان البحث :
 ycneicifeD norI gnitceffa srotcaf lanoitirtuN ehT
 knaB tseW eht ni nemoW tnangerP gnoma aimenA
ه الفلسطٌنٌه الاولٌة التابعة لوزارة الصحٌة الموقع: حٌث سٌتم اجراء الدراسة فً عٌادات الرعا 
 فً نابلس ورام الله والخلٌل .
 أنا الباحثه نٌفٌن وجٌه شلالفه أقوم ببحث بعنوان :
 gnoma aimenA ycneicifeD norI gnitceffa srotcaf lanoitirtuN ehT
 knaB tseW eht ni nemoW tnangerP
دٌه الى فقر دم الحدٌد لدى النساء هذا البحث ٌهتم بدراسة العوامل التغذوٌه المؤ
أقوم  بتجمٌع معلومات من خلال هذه الدراسة سالحوامل فً الضفه الغربٌه , من 
وصات الطبٌة خاصه فحص الدم والسٌره  النسائٌه لها علاقة بنتائج الفحملفاتكن 
وتعبئه السجل  بانة من خلال توجٌه الاسئلة لكنتوكذلك تعبئة اس الطبٌه والصحٌه 
لن تستخدم هذه ا لمعلومات الا لاغراض البحث العملً فقط ئائً لمده ثلاثه أٌام , الغ
فى هذا البحث العلمى لك الحرٌة فً طرح أى سؤال أو إستفسار عن  ه. كمشارك
ركة بهذا البحث هذا البحث خلال اي مرحلة من المرحل. ٌرجى العلم بأن المشا
ة او عدمها. قراركم بعدم المشاركة الحرٌة المطلقة بالموافق عمل طوعً بحت ولكن
 فى هذا البحث العلمى لا ٌترتب علٌه اى تبعات.
لقد قرأت الوصف أعلاه من هذه الدراسة. وقد تمت الاجابة على جمٌع أسئلتً.  
وأنا أعلم أنه ٌمكننً ان ارفض المشاركة. أعطً موافقتً بحرٌة على المشاركة فً 
 ............. توقٌع المشارك: .....     .......هذه الدراسة . اسم المشارك .
 نٌفٌن شلالفه الباحث:
 9597117950رقم الهاتف 
 مشرفه الدراسه: د.أمٌره عمرو
